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Increasing the price of cigarettes can reduce smoking sub-
stantially by discouraging initiation among youths and young 
adults, prompting quit attempts, and reducing average cigarette 
consumption among those who continue to smoke (1–3). 
Increasing cigarette excise taxes is one of the most effective 
tobacco control policies because it directly increases cigarette 
prices, thereby reducing cigarette use and smoking-related death 
and disease (1). All states and the District of Columbia (DC) 
impose an excise tax on cigarettes (1). Because many states 
increased their cigarette excise taxes in 2009, CDC conducted 
a survey of these tax increases. For this report, CDC reviewed 
data contained in a legislative database to identify cigarette 
excise tax legislation that was enacted during 2009 by the 50 
states and DC. During that period, 15 states (including DC), 
increased their state excise tax on cigarettes, increasing the 
national mean from $1.18 per pack in 2008 to $1.34 per pack in 
2009. However, none of the 15 states dedicated any of the new 
excise tax revenue by statute to tobacco control. Additionally, for 
the first time, two states (Connecticut and Rhode Island) had 
excise tax rates of at least $3.00 per pack. Additional increases 
in cigarette excise taxes, and dedication of all resulting revenues 
to tobacco control and prevention programs at levels recom-
mended by CDC, could result in further reductions in smoking 
and associated morbidity and mortality (2,4). 
Cigarettes and other tobacco products are taxed by federal, 
state, and local governments in various ways, including excise 
taxes, which typically are levied per pack of 20 cigarettes (1). 
State cigarette excise tax rates are set by legislation, are contained 
in state statutes, and usually are collected before the point of 
sale (i.e., from manufacturers, wholesalers, or distributors), as 
denoted by a tax stamp. Forty-four states and DC also levy state 
sales taxes on the retail sale of cigarettes (5).  
State cigarette excise tax data for this report were obtained 
from CDC’s State Tobacco Activities Tracking and Evaluation 
(STATE) system database, which contains tobacco-related 
epidemiologic and economic data and information on state 
tobacco-related legislation. Data are collected quarterly from 
an online legal research database of state laws, analyzed, coded, 
and transferred into the STATE system. The STATE system 
contains information on state laws on excise taxes for cigarettes 
in effect since the fourth quarter of 1995. 
All states and DC impose an excise tax on cigarettes (1) 
(Figure 1). During 2009, cigarette excise tax increases were 
enacted and took effect in 15 states: Arkansas, Connecticut, 
Delaware, DC, Florida, Hawaii, Kentucky, Mississippi, New 
Hampshire, New Jersey, North Carolina, Pennsylvania, Rhode 
Island, Vermont, and Wisconsin (Table). No state decreased 
its excise tax. The increases ranged from $0.10 per pack in 
North Carolina to $1.00 per pack in Connecticut, Florida, and 
Rhode Island. For states with an excise tax increase in 2009, 
the mean increase was $0.52 per pack. The increases resulted 
in Connecticut and Rhode Island becoming the first two states 
with a cigarette excise tax of at least $3.00 per pack (Table). 
Additionally, Hawaii included a provision in the state law that 
will increase the state cigarette excise tax by $0.20 per year in 
July 2010 and 2011, bringing the state tax to $3.00 per pack.
The national mean cigarette excise tax among all states 
increased from $1.18 per pack in 2008 to $1.34 per pack in 
2009. South Carolina had the lowest state cigarette excise tax in 
the United States, at $0.07 per pack, and Rhode Island had the 
highest, at $3.46 per pack (Table). Among major tobacco-grow-
ing states (Georgia, Kentucky, North Carolina, South Carolina, 
Tennessee, and Virginia), the mean state cigarette excise tax was 
$0.40 per pack on December 31, 2009, an increase from $0.28 
in 2008. For all other states, including DC, the mean cigarette 
excise tax was $1.46 per pack on December 31, 2009, an increase 
from $1.30 in 2008. 
State Cigarette Excise Taxes — United States, 2009
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California, Missouri, North Dakota, and South 
Carolina remain the only states that have not increased 
their state cigarette excise tax in the past decade. South 
Carolina’s cigarette excise tax of $0.07 per pack has not 
increased since 1977. Missouri and North Dakota have 
not raised the state cigarette excise tax ($0.17 and $0.44 
per pack, respectively) since 1993, and California has 
not raised its $0.87 per pack tax since 1998. 
Reported by
K Debrot, DrPH, M Tynan, J Francis, MPH, A MacNeil, 
MPH, Office on Smoking and Health, National Center for 
Chronic Disease Prevention and Health Promotion, CDC. 
Editorial Note
Cigarette excise tax increases reduce tobacco use and 
initiation. A 10% increase in the price of cigarettes can 
reduce consumption by nearly 4% among adults (3) and 
can have an even greater effect among youths and other 
price-sensitive groups (6,7). When combined with other 
evidence-based components of comprehensive tobacco 
control programs, cigarette excise tax increases can be 
even more effective in reducing tobacco-related death and 
SOURCE: CDC, Office on Smoking and Health. State Tobacco Activities Tracking and Evaluation 
(STATE) system.  
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disease (2). Excise tax increases also can serve as a revenue 
source to fund and expand state tobacco control pro-
grams, further reducing tobacco use and disease (2,4). For 
example, if every state were to increase its cigarette excise 
tax by $1.00, even accounting for the resulting decrease 
in consumption, an estimated $9.1 billion in additional 
revenue would be generated each year in the United States 
(8). Additionally, approximately 1 million premature 
smoking-caused deaths would be prevented, and 2.3 mil-
lion children would not initiate smoking (8). 
Although Kentucky and North Carolina, the two 
major tobacco-growing states, did increase their ciga-
rette excise taxes in 2009, the cigarette excise taxes in 
these states remain among the lowest in the country 
(Figure 1). The individual cigarette excise tax rates in 
tobacco-growing and bordering southeastern states 
remain substantially lower than the rest of the country. 
These states typically have higher smoking rates and 
do not have strong tobacco control policies, such as 
comprehensive state smoke-free laws.*
The tax increases described in this report are a part 
of a general rise in cigarette excise taxes in the United 
States during the past decade (9). The Institute of 
Medicine (IOM) noted in 2007 that recent cigarette 
excise tax increases had largely been in response to 
state budget shortfalls (2), which also might explain 
the high number of states that increased their cigarette 
excise tax rates in 2009. The Healthy People 2010 
objective (27-21a)† to increase the combined federal 
and mean state excise tax to at least $2.00 per pack 
also was achieved in 2009 (Figure 2) (9). In 2009, the 
combined federal and mean state cigarette excise tax 
* Data available at http://www.cdc.gov/tobacco/statesystem.
† Available at http://www.healthypeople.gov/document/pdf/
volume2/27tobacco.pdf.
TABLE. State excise taxes per pack of 20 cigarettes, amount 
increased during 2009, and change from 2008, by state — 










Rhode Island 3.46 1.00 40.7
Connecticut 3.00 1.00 50.0
New York 2.75 —§ —
New Jersey 2.70 0.125 4.9
Hawaii 2.60 0.60 30.0
Wisconsin 2.52 0.75 42.4
Massachusetts 2.51 — —
District of Columbia 2.50 0.50 25.0
Vermont 2.24 0.25 12.6
Washington 2.025 — —
Alaska 2.00 — —
Arizona 2.00 — —
Maine 2.00 — —
Maryland 2.00 — —
Michigan 2.00 — —
New Hampshire 1.78 0.45 33.8
Montana 1.70 — —
Delaware 1.60 0.45 39.1
Pennsylvania 1.60 0.25 18.5
South Dakota 1.53 — —
Texas 1.41 — —
Iowa 1.36 — —
Florida 1.339 1.00 295.0
Ohio 1.25 — —
Minnesota 1.23 — —
Oregon 1.18 — —
Arkansas 1.15 0.56 94.9
Oklahoma 1.03 — —
Indiana 0.995 — —
Illinois 0.98 — —
New Mexico 0.91 — —
California 0.87 — —
Colorado 0.84 — —
Nevada 0.80 — —
Kansas 0.79 — —
Utah 0.695 — —
Mississippi 0.68 0.50 277.8
Nebraska 0.64 — —
Tennessee¶ 0.62 — —
Kentucky¶ 0.60 0.30 100.0
Wyoming 0.60 — —
Idaho 0.57 — —
West Virginia 0.55 — —
North Carolina¶ 0.45 0.10 28.6
North Dakota 0.44 — —
Alabama 0.425 — —
Georgia¶ 0.37 — —
Louisiana 0.36 — —
Virginia¶ 0.30 — —
Missouri 0.17 — —
South Carolina¶ 0.07 — —
State mean 1.337 0.522** 64.0**
 * Available at http://www.cdc.gov/tobacco/statesystem.
 † Includes the District of Columbia.
 § No change during 2009.
 ¶ Major tobacco-growing state.
 ** Among states that increased excise taxes in 2009.
What is already known on this topic?
Increasing cigarette excise taxes is one of the most effective tobacco control 
policies because it directly increases cigarette prices, thereby reducing 
cigarette use and smoking-related death and disease.
What is added by this report?
During 2009, 15 states (including the District of Columbia) increased their 
state cigarette excise taxes; however, none of these states dedicated any of 
the new revenue to tobacco control.
What are the implications for public health practice?
Dedicating revenues from cigarette excise tax increases to tobacco control 
programs could complement the effect of excise taxes in discouraging youth 
smoking initiation, increasing quit attempts, and decreasing the number of 
cigarettes consumed by those who continue to smoke.
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was $2.35 per pack. This goal was achieved because 
of an increase in the federal cigarette excise tax, which 
increased from $0.39 per pack to $1.01 per pack on 
April 1, 2009. Had the federal cigarette excise tax not 
taken effect by the end of 2009, the combined taxes 
would have been $0.27 per pack below the Healthy 
People 2010 target. 
CDC recommends that states invest $9.23–$18.02 
per capita on comprehensive tobacco control pro-
grams (4), which have been shown to decrease ciga-
rette smoking (2,4). Funding comprehensive tobacco 
control programs also can reduce health-care expendi-
tures dramatically within a state. In 1988, California 
established a state tobacco control program funded 
by a portion of the state’s cigarette excise tax revenue 
(10). In the first 15 years of funding, the $1.8 billion 
invested in the California tobacco control program 
resulted in an estimated $86 billion in savings in 
personal health-care expenditures (10). 
The findings in this report are subject to at least one 
limitation. The STATE system tracks only state-level 
data and does not include data on local (county, city, or 
other jurisdiction) taxes. Although not included in this 
analysis, approximately 460 communities impose a local 
tax on cigarettes, including New York City ($1.50 per 
pack) and Chicago-Cook County ($2.68 per pack).¶ 
IOM recommends that states increase their cigarette 
excise tax and dedicate a portion of the revenue from 
these increases to fund comprehensive tobacco con-
trol programs at the state-specific level recommended 
by CDC (2). The more that states spend on tobacco 
control programs, the greater the reductions in smok-
ing, and the longer states invest in such programs, 
the greater the effect (4). With fully funded and sus-
tained tobacco control programs complemented with 
strong tobacco control policies (e.g. cigarette excise 
tax increases, comprehensive smoke-free policies, and 
counter-marketing campaigns), IOM’s best-case sce-
nario for reducing smoking prevalence in the United 
States to 10% by 2025 would be attainable (2,4). 
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Cigarette price increases reduce the demand for 
cigarettes and thereby reduce smoking prevalence, 
cigarette consumption, and youth initiation of smok-
ing (1,2). Excise tax increases are the most effective 
government intervention to increase the price of 
cigarettes (1), but cigarette manufacturers use trade 
discounts, coupons, and other promotions to counter-
act the effects of these tax increases (3) and appeal to 
price-sensitive smokers (4). State cigarette minimum 
price laws, initiated by states in the 1940s and 1950s 
to protect tobacco retailers from predatory business 
practices (5,6), typically require a minimum percent-
age markup to be added to the wholesale and/or retail 
price. If a statute prohibits trade discounts from the 
minimum price calculation, these laws have the poten-
tial to counteract discounting by cigarette manufac-
turers (5). To assess the status of cigarette minimum 
price laws in the United States, CDC surveyed state 
statutes and identified those states with minimum 
price laws in effect as of December 31, 2009. This 
report summarizes the results of that survey, which 
determined that 25 states had minimum price laws for 
cigarettes (median wholesale markup: 4.00%; median 
retail markup: 8.00%), and seven of those states also 
expressly prohibited the use of trade discounts in the 
minimum retail price calculation. Minimum price 
laws can help prevent trade discounting from eroding 
the positive effects of state excise tax increases and 
higher cigarette prices on public health (5).
Cigarette prices are increased by several factors, 
including 1) federal and state excise taxes, which are 
applied per pack of 20 cigarettes, and 2) percentage 
markups by wholesalers and retailers (Table 1). All 
50 states and the District of Columbia (DC) add a 
state excise tax to the manufacturer’s invoice price 
(7); the result is referred to as the manufacturer base 
price. In certain states, state cigarette minimum price 
laws require the addition of a minimum percentage 
markup by the cigarette wholesaler to the base price, 
which results in the wholesale price. Most states with 
minimum price laws also require the addition of a 
minimum percentage markup by the cigarette retailer 
(6). The result is the minimum retail price charged 
to the consumer. The cigarette minimum price laws 
in some states also expressly allow or prohibit trade 
discounts (i.e., reductions in price) from cigarette 
manufacturers to wholesalers or retailers in calculating 
the minimum retail price to consumers. Allowing 
trade discounts can partially reduce the price increases 
from taxes and minimum markups, which leads to a 
lower minimum price (Table 1).
To conduct this survey, CDC researchers first 
reviewed eight known cigarette minimum price stat-
utes (6) for Boolean search terms that would identify 
all other such statutes in a database of current statutes 
for all 50 states and DC. Identified statutes were then 
analyzed to determine 1) the minimum percentage 
markup that must be applied to cigarette prices by 
wholesalers and/or retailers, or the actual minimum 
price required by the law; 2) whether the statute 
allows or prohibits trade discounts to be considered 
in calculating minimum price; and 3) the state agency 
or officer with regulatory enforcement authority. To 
ensure that all state cigarette minimum price laws were 
identified, researchers also reviewed all pricing laws 
in those states that appeared not to have a minimum 
price law. When a statute indicated that wholesal-
ers must apply a minimum percentage markup for 
transportation costs, that percentage was included in 
the wholesale minimum markup. 
As of December 31, 2009, 25 states* had statu-
tory minimum prices for cigarettes (Table 2). The 
minimum percentage by which these states required 
markup on the wholesale price of cigarettes ranged 
from 2.00% in DC, Louisiana, and Mississippi to 
6.50% in Connecticut. The median required whole-
sale percentage markup among the 25 states was 
4.00%. The minimum percentage by which states 
required a markup on the retail price of cigarettes 
ranged from 6.00% in six states (Alaska, Louisiana, 
Mississippi, Oklahoma, Pennsylvania, and Wisconsin) 
to 25.00% in Massachusetts. The median required 
retail percentage markup among the 25 states was 
8.00%. The minimum price laws in Rhode Island and 
Washington did not require a percentage markup for 
either wholesale or retail; instead, the state statutes 
set the minimum price as the “replacement cost” 
and “actual price paid,” respectively. Additionally, 
Delaware was the only state with a minimum price 
for wholesalers but not for retailers, and Tennessee 
was the only state with a minimum price for retailers 
but not for wholesalers. 
State Cigarette Minimum Price Laws — United States, 2009
* For this report, DC is included among states.
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Seven of the 25 states with minimum price laws 
(Arkansas, DC, Minnesota, Montana, Nebraska, 
New York, and Pennsylvania) expressly prohibit trade 
discounts in calculating the minimum retail price for 
cigarettes (Table 2). Fourteen of the states expressly 
allow trade discounts to be taken into account when 
calculating minimum price. Cigarette minimum price 
statutes in four other states (Iowa, Massachusetts, 
Rhode Island, and Washington) neither expressly pro-
hibit nor expressly allow trade discounts in calculating 
the minimum retail price for cigarettes.
Reported by
KM Ribisl, PhD, Gillings School of Global Public Health, 
Univ of North Carolina, Chapel Hill, North Carolina. 
R Patrick, JD, S Eidson JD, MayaTech Corporation, Silver 
Spring, Maryland. M Tynan, J Francis, MPH, Office on 
Smoking and Health, National Center for Chronic Disease 
Prevention and Health Promotion, CDC.
Editorial Note
Increasing the price of tobacco products is an 
evidence-based tobacco control strategy that can pro-
duce substantial long-term improvements in health 
(1). Cigarette tax increases are the most effective and 
direct way that governments can increase the price 
of cigarettes (1,2). However,  cigarette manufacturers 
spent $12.5 billion on marketing and promotional 
expenditures in 2006, 74% of which was spent to 
reduce the price of cigarettes at the point of sale (8). 
Although 15 states increased their cigarette excise tax 
rates in 2009 (7), the impact of those increases on 
consumer prices might have been blunted by trade 
discounts from cigarette manufacturers. Cigarette 
minimum price laws, which were initiated by states 
in the 1940s and 1950s to protect tobacco retailers 
from predatory business practices by large retailers 
(e.g., selling an item at a price below cost to attract 
more customers into a store) (5,6), have the poten-
tial to counteract trade discounting. Although excise 
tax increases remain the most direct way for states 
to increase the price of cigarettes (1), creating or 
strengthening minimum price laws is another way to 
increase cigarette prices.
Cigarette minimum price laws also have the poten-
tial to increase the consumer price of cigarettes in 
states with low cigarette excise tax rates (6). Currently, 
of the states with the 10 lowest state excise taxes, only 
one state (Louisiana) has a minimum price law. States 
with average-to-high excise tax rates also might benefit 
from minimum price laws, by using them to mitigate 
the effect discounting by cigarette manufacturers has 
on cigarette prices. Currently, of the 10 states with 
the highest excise taxes, eight states (all but Hawaii 
and Vermont) have a minimum price law. Although 
minimum price laws that expressly prohibit trade 
discounts from being considered when calculating 
minimum price can help preserve the beneficial public 
health impact of tax increases (6), additional laws 
might be necessary to prohibit all retail price promo-
tions (e.g., coupons or two-for-one offers) that can 
decrease cigarette retail prices to consumers.
The findings in this report are subject to at least 
three limitations. First, this survey only includes states 
with minimum price laws that apply specifically to 
cigarettes. At least seven other states† have general 
minimum price laws (9) that apply to other types 
† California, Colorado, Michigan, North Dakota, South Carolina, 
West Virginia, and Wyoming.
TABLE 1. Hypothetical example of calculation of the minimum retail price of a pack of cigarettes, using a state minimum price 
law that prohibits and one that allows trade discounts — United States, 2009







Manufacturer invoice price of a pack of brand-name cigarettes* 3.40 3.40
Federal excise tax (rounded from $1.0066) +1.01 +1.01
State excise tax† +1.34 +1.34
Manufacturer base price 5.75 5.75
Wholesale markup (4.0%§) +0.23 +0.23
Minimum wholesale price 5.98 5.98
Trade discount ($0.50) — -0.50
Minimum wholesale price after trade discount¶ 5.98 5.48
Retail markup (8%§) +0.48 +0.44
Minimum retail price to consumer 6.46 5.92
* Actual manufacturer price might be higher or lower depending on the state and brand of cigarettes.
† Average among states, as of December 31, 2009.
§ Median among states, as of December 31, 2009.
¶ Actual trade discount might be higher or lower depending on the state and brand of cigarettes.
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or classes of goods but that also might be applicable 
to cigarettes or amendable to apply to cigarettes. 
Second, this survey only includes state statutes on 
minimum pricing for cigarettes and does not include 
other actions (e.g., attorney general opinions, case 
law decisions, and regulatory guidelines) that might 
affect how the statutes are implemented or might be 
affected if challenged legally. Finally, this survey did 
not evaluate how rigorously states enforce their ciga-
rette minimum price laws, which might vary among 
states or over time. 
TABLE 2. Statutory cigarette minimum price markups and provisions for trade discounts, ranked by state cigarette excise tax — United States, 2009*
State†
State excise tax per 
pack of 20 cigarettes
($)








State agency or officer with 
regulatory enforcement authority
Rhode Island 3.46 Replacement cost§ Replacement cost Not mentioned¶ Not identified
Connecticut 3.00 6.50 8.00 Allowed Not identified
New York 2.75 3.00 7.00 Prohibited Tax Commission
New Jersey 2.70 6.00 8.00 Allowed Director of the Division of Taxation
Hawaii 2.60 —** — NA†† NA
Wisconsin 2.52 3.00 6.00 Allowed Not identified
Massachusetts 2.51 2.75 25.00 Not mentioned Not identified
District of Columbia 2.50 2.00 8.00 Prohibited Mayor
Vermont 2.20 — — NA NA
Washington 2.025 Actual price§ Actual price Not mentioned Not identified
Alaska 2.00 4.50 6.00 Allowed Department of Revenue
Arizona 2.00 — — NA NA
Maine 2.00 — — NA NA
Maryland 2.00 5.00 8.00 Allowed Not identified
Michigan 2.00 — — NA NA
New Hampshire 1.78 — — NA NA
Montana 1.70 5.75 10.00 Prohibited Not identified
Delaware 1.60 5.00 — Allowed Secretary of Finance
Pennsylvania 1.60 4.00 6.00 Prohibited Department of Revenue
South Dakota 1.53 5.50 8.00 Allowed Secretary of Revenue and Regulation
Texas 1.41 — — NA NA
Iowa 1.36 4.00 8.00 Not mentioned Not identified
Florida 1.339 — — NA NA
Ohio 1.25 3.50 8.75 Allowed Tax Commissioner
Minnesota 1.23 4.50 8.00 Prohibited Not identified
Oregon 1.18 — — NA NA
Arkansas 1.15 4.00 7.50 Prohibited Director of the Arkansas Tobacco Control Board
Oklahoma 1.03 2.75 6.00 Allowed Tax Commission
Indiana 0.995 4.50 8.00 Allowed Alcohol and Tobacco Commissioner
Illinois 0.98 — — NA NA
New Mexico 0.91 — — NA NA
California 0.87 — — NA NA
Colorado 0.84 — — NA NA
Nevada 0.80 — — NA NA
Kansas 0.79 — — NA NA
Utah 0.695 — — NA NA
Mississippi 0.68 2.00 6.00 Allowed Tax Commission
Nebraska 0.64 4.75 8.00 Prohibited Cigarette Tax Division or Tax Commissioner
Tennessee 0.62 — 8.00 Allowed Commissioner of Revenue
Kentucky 0.60 2.75 8.00 Allowed Department of Revenue
Wyoming 0.60 — — NA NA
Idaho 0.57 — — NA NA
West Virginia 0.55 — — NA NA
North Carolina 0.45 — — NA NA
North Dakota 0.44 — — NA NA
Alabama 0.425 — — NA NA
Georgia 0.37 — — NA NA
Louisiana 0.36 2.00 6.00 Allowed Not identified
Virginia 0.30 — — NA NA
Missouri 0.17 — — NA NA
South Carolina 0.07 — — NA NA
 * As of December 31, 2009.
 † Includes District of  Columbia.
 § A provision that prevents cigarettes from being sold for a loss of revenue (e.g., wholesaler may not sell at less than invoice price; retailer may not sell at less than wholesale price). 
 ¶ Not expressly addressed by the cigarette minimum price statute.
 ** No law.
 †† Not applicable.
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More research is needed to determine how cigarette 
minimum price laws affect consumer prices and state 
revenue from tobacco products (5). State tobacco-
control programs can partner with state tax depart-
ments or other state agencies with regulatory enforce-
ment authority over cigarette minimum price laws to 
determine how these laws are enforced. The programs 
also can identify gaps in the law that might be used by 
cigarette manufacturers and retailers to reduce cigarette 
prices (e.g., remote sales via the Internet and mail order, 
direct sales from manufacturers to consumers, or cou-
pons and other direct-to-consumer discounts). 
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What is already known on this topic?
Cigarette minimum price laws were developed by 
states in the 1940s and 1950s to protect tobacco 
retailers from predatory business practices, but these 
laws also have the potential to increase cigarette 
prices and to counteract price discounting by ciga-
rette manufacturers.
What is added by this report?
A survey of all state cigarette minimum price laws 
indicated that 25 states had cigarette minimum price 
laws at the end of 2009, and seven of those states 
prohibited using trade discounts in the calculation of 
minimum prices.
What are the implications for public health practice?
State tobacco control programs can partner with the state 
tax agencies and others to determine how these laws 
are enforced and to identify gaps that might be used by 
cigarette manufacturers to reduce cigarette prices.
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On October 19, 2009, clinicians from Kentucky 
contacted CDC regarding a suspected case of rabies in 
a man from Indiana aged 43 years. This report sum-
marizes the patient’s clinical presentation and course, 
the subsequent epidemiologic investigation, and, for 
the first time, provides infection control recommenda-
tions for personnel performing autopsies on decedents 
with confirmed or suspected rabies infection. Before 
the patient’s death on October 20, a diagnosis of rabies 
was suspected based on the history of acute, progres-
sive encephalitis with unknown etiology. Preliminary 
serology results on antemortem serum samples detected 
rabies virus-specific antibodies. Because local patholo-
gists were concerned about the biosafety risk posed by 
infectious aerosols at autopsy and potential contami-
nation of autopsy facilities, the Kentucky Department 
for Public Health (KDPH) asked CDC staff members 
to travel to Kentucky and perform an autopsy to 
confirm the diagnosis and assist with the epidemio-
logic investigation. Testing of autopsy samples was 
conducted at CDC and detected rabies virus antigens 
in brainstem and cerebellum. Rabies viral RNA was 
isolated and typed as a variant common to the tricol-
ored bat (Perimyotis subflavus). Although rabies virus 
transmission from organ or tissue transplant has been 
documented rarely (1,2), transmission of rabies virus 
to persons performing autopsies has not been reported. 
Autopsies can be performed safely on decedents with 
confirmed or suspected rabies using careful dissection 
techniques, personal protective equipment, and other 
recommended precautions.
Case Report 
On October 5, 2009, a previously healthy man 
from Indiana aged 43 years visited an employee 
health clinic with fever and cough. His vital signs 
and physical examination were unremarkable except 
for coarse rales on lung auscultation. The clinician 
made a diagnosis of bronchitis, prescribed antibiot-
ics, and asked the patient to return the following day. 
At this follow-up appointment, the patient reported 
worsening fever and chills, as well as new chest pain 
and left arm numbness; he also exhibited decreased 
grip strength of the left hand. An electrocardiogram 
showed no evidence of cardiac ischemia. Later that 
day, an evaluation at a local emergency department 
was similarly unrevealing, and the patient was given 
narcotics and muscle relaxants for presumed muscu-
loskeletal pain and discharged home. 
On October 7, the patient returned to the same 
ED, where he was noted to have akathisia and motor 
restlessness thought to be side effects from the muscle 
relaxant. The ED physician advised admission to 
the hospital, but the patient returned home. Upon 
follow-up the next day with a primary-care physician, 
the patient had prominent muscle fasciculations, 
fever, tachycardia, and hypotension. Given these signs, 
the physician was concerned about the possibility of 
sepsis and admitted him to the hospital. 
After admission, the patient’s mental status deterio-
rated rapidly, and he underwent endotracheal intubation 
for airway protection. On October 9, he was transferred 
to a referral hospital in the neighboring state of Kentucky. 
A lumbar puncture yielded cerebrospinal fluid (CSF) 
with glucose of 72 mg/dL (normal: 40–70 mg/dL), 
protein 140 mg/dL (normal: 15–45 mg/dL), 3 red 
blood cells/mm3 (normal: 0–2 cells/mm3), and 38 
white blood cells /mm3 (normal: 0–5 cells/mm3); dif-
ferential showed 99% lymphocytes and 1% monocytes. 
During October 9–19, no etiology for the patient’s 
disease was identified, and his hospital course became 
complicated by bradycardia, hypotension, rhabdomy-
olysis, and renal failure requiring hemodialysis. Results 
of a magnetic resonance image of the brain and a brain 
perfusion study were normal. Bacterial and fungal cul-
tures of CSF, in addition to laboratory tests for West 
Nile virus, herpes simplex virus, influenza, and human 
immunodeficiency virus, were negative. 
On October 19, diagnostic testing for rabies was 
requested, and samples of the patient’s serum, saliva, 
and a nuchal skin biopsy were sent to CDC for 
analysis. However, on October 20, while these tests 
were pending, the patient’s physical examination, 
electroencephalogram, and apnea testing all indicated 
brain death. Ventilatory support was withdrawn, and 
the patient died on October 20. 
Postmortem Findings
On October 22, testing at CDC indicated rabies 
specific immunoglobulin G (1:2,048) and immu-
noglobulin M (1:512) antibodies in serum by the 
indirect fluorescent-antibody (IFA) assay. Subsequent 
testing detected rabies virus neutralizing antibodies 
(0.44 IU/mL) in serum by rapid fluorescent focus 
Human Rabies — Kentucky/Indiana, 2009 
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inhibition test (RFFIT). The formalin-fixed nuchal 
skin biopsy specimen tested negative for viral antigens 
by immunohistochemistry (IHC). On October 27, 
a CSF sample collected on October 11 and located 
postmortem was sent to CDC and also tested negative 
for rabies antibodies by IFA and RFFIT. The family 
requested an autopsy, but pathologists at the referral 
hospital were concerned about the biosafety risk posed 
by infectious aerosols at autopsy and potential con-
tamination of autopsy facilities. Attempts to identify 
other personnel and facilities willing to perform the 
autopsy, including several tertiary-care and teaching 
centers in Kentucky, Indiana, and Tennessee, were 
unsuccessful because of similar concerns. In response 
to a request for assistance from KDPH, CDC staff 
members traveled to Kentucky and performed an 
autopsy limited to the head to collect tissue specimens 
for diagnostic evaluation. 
At autopsy, the brain weighed 1,610 g (nor-
mal: 1,300–1,400 g) and showed markedly con-
gested and hemorrhagic leptomeninges (Figure 1). 
Histopathologic examination revealed encephalomy-
elitis and abundant neuronal cytoplasmic inclusions 
(Negri bodies) (Figure 2). Rabies virus antigens were 
detected in multiple samples of fresh central nervous 
system (CNS) tissue by direct fluorescent antibody 
(DFA) testing and in formalin-fixed CNS tissues 
by IHC (Figure 2). Viral RNA was detected in the 
patient’s saliva collected antemortem and CNS tis-
sues collected at autopsy by reverse transcription–
polymerase chain reaction and was typed as a variant 
common to the tricolored bat (Perimyotis subflavus). 
Public Health Investigation 
The referral hospital and CDC notified KDPH 
and the Indiana State Department of Health (ISDH) 
about the case on October 21, the day before rabies 
virus-specific antibodies were found in the patient’s 
serum. Beginning on October 23, ISDH, with the 
assistance of the local health department and, later, 
CDC, began interviewing the patient’s close contacts, 
including family, friends, coworkers, and health-care 
personnel, to clarify his exposure history and deter-
mine whether rabies postexposure prophylaxis (PEP) 
should be recommended to any of the contacts. The 
investigation identified no specific source of rabies 
virus exposure. However, the patient, who worked 
as a mechanic and lived in a farming community in 
southern Indiana, had mentioned to his friends that 
he had seen a bat in late July after removing a tarpaulin 
from a tractor adjacent to his residence. He had not 
mentioned a bite or a nonbite exposure associated 
with this or any other incident. 
The investigation identified 159 persons who had 
interaction with the patient 2 weeks before or dur-
ing the 2-week duration of his illness. All of these 
159 persons were counseled about the potential risks 
associated with rabies virus exposure. Investigators 
distributed a handout detailing basic information 
about rabies, how the virus is transmitted, and what 
constitutes an exposure. Of the 159 persons, 147 were 
health-care providers who treated the patient during 
his visits to four medical facilities, or who transported 
him between hospitals. Two family members, two 
coworkers, and 14 health-care providers were identi-
fied as having been potentially exposed to saliva from 
the patient. All 18 were recommended to receive 
rabies PEP, and all completed the vaccination series 
according to Advisory Committee for Immunization 
Practices (ACIP) recommendations (3,4). To date, 
none of the 159 persons has developed rabies.
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FIGURE 1. Brain at autopsy of a decedent with suspected 
rabies infection, showing markedly congested and hemor-
rhagic leptomeninges — Kentucky/Indiana, 2009
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Editorial Note
The case described in this report represents the 
first rabies death in an Indiana resident since 2006 
and only the second such death since 1959. Including 
this case, a total of 31 cases of human rabies have been 
reported in the United States since 2000. Of these, 14 
(45%) were diagnosed postmortem, reinforcing the 
need to consider rabies in all cases of acute progressive 
encephalitis of unknown etiology. Human rabies cases 
in the United States might be underreported because 
of lack of recognition and lack of confirmation by 
diagnostic testing. When rabies is suspected, ante-
mortem diagnosis requires testing of serum, saliva, 
CSF, and a nuchal skin biopsy. 
The postmortem diagnosis of rabies is made by 
examination of tissue from the brain (e.g., medulla, 
cerebellum, and hippocampus). Autopsies fulfill an 
important function by diagnosing cases of rabies and 
furthering understanding of the disease. By provid-
ing a diagnosis for deceased patients with suspected 
but unconfirmed rabies, or for patients in whom the 
disease was never suspected clinically, autopsies can 
1) aid the public health investigation, 2) help raise 
public awareness of rabies associated with specific 
exposures, 3) emphasize the importance of seeking 
medical evaluation after such an exposure occurs, 
and 4) add to knowledge about current human rabies 
incidence. In patients with confirmed rabies, autopsies 
provide information about pathogenesis that might 
be relevant to investigations of treatment.
Although contact with decedents with confirmed 
or suspected rabies can cause anxiety, no confirmed 
case of rabies has ever been reported among persons 
performing postmortem examinations of humans 
or animals. Even from living patients with rabies, 
human-to-human transmission has been documented 
only rarely, in cases of organ or tissue transplanta-
tion (1,2). Aerosol transmission of rabies virus has 
never been well documented outside of a research 
laboratory setting (5). Both CDC and the World 
Health Organization (WHO) have stated that the 
infection risk to health-care personnel from human 
rabies patients is no greater than from patients with 
other viral or bacterial infections. In addition, rabies 
PEP is available for exposed personnel. Nevertheless, 
because of the nearly universal fatal outcome from 
rabies, both CDC and WHO recommend that all 
personnel working with rabies patients or decedents 
adhere to recommended precautions (3,6). 
Even the minimal risk for rabies virus transmission at 
autopsy can be reduced by using careful dissection tech-
niques and appropriate personal protective equipment, 
including an N95 or higher respirator, full face shield, 
goggles, gloves, complete body coverage by protective 
wear, and heavy or chain mail gloves to help prevent 
cuts or sticks from sharp instruments or bone fragments 
(Box). Aerosols should be minimized by using a handsaw 
rather than an oscillating saw, and by avoiding contact 
of the saw blade with brain tissue while removing the 
calvarium. Ample use of a 10% solution of sodium 
hypochlorite for disinfection is recommended both dur-
ing and after the procedure to ensure decontamination 
of all exposed surfaces and equipment. Participation 
in the autopsy should be limited to persons directly 
involved in the procedure and collection of specimens. 
Previous vaccination against rabies is not required for 
FIGURE 2. Histopathologic examination of central nervous system tissue from 
autopsy of a decedent with suspected rabies infection, showing neuronal cyto-
plasmic inclusions (Negri bodies) after hematoxylin and eosin staining (panel A) 





What is already known on this topic?
If not prevented by administration of postexposure 
prophylaxis, the rabies virus causes an acute progres-
sive viral encephalitis that is almost always fatal.
What is added by this report?
In October 2009, a man from Indiana aged 43 years 
died of rabies; the diagnosis was made postmortem 
and confirmed by samples collected at autopsy.
What are the implications for public health practice?
Recognizing and diagnosing human rabies is critical 
in initiating an appropriate clinical and public health 
response, furthering understanding of the disease, 
and implementing appropriate prevention and con-
trol measures; autopsies can be performed safely on 
decedents with confirmed or suspected rabies using 
careful dissection techniques, personal protective 
equipment, and other recommended precautions.
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persons performing such autopsies. PEP of autopsy 
personnel is recommended only if contamination of 
a wound or mucous membrane with patient saliva or 
other potentially infectious material (e.g., neural tissue) 
occurs during the procedure (3,7,8). The case described 
in this report highlights the need to educate pathologists 
and other hospital personnel about appropriate rabies 
infection control procedures so that autopsies can be 
performed safely in cases of confirmed or suspected 
human rabies.
BOX. CDC recommendations for performing autopsies of 
humans with confirmed or suspected rabies
•	 Use	personal	protective	equipment,	including	
an N95 or higher respirator, full face shield, 
goggles, and gloves, as well as complete body 
coverage with protective wear.
•	 Use	heavy	or	chain	mail	gloves	to	help	prevent	
cuts or sticks from cutting instruments or 
bone fragments.
•	Minimize	 aerosol	 generation	 by	 using	 a	
handsaw rather than an oscillating saw and 
avoiding contact of the saw blade with brain 
tissue while removing the calvarium.
•	 Limit	 participation	 to	 those	 directly	
involved in the procedure and collection of 
specimens.
•	 Use	 ample	 amounts	 of	 a	 10%	 sodium	
hypochlorite solution during and after the 
procedure to ensure decontamination of all 
exposed surfaces and equipment
•	 Previous vaccination against rabies is not 
required for persons performing such 
autopsies, and postexposure prophylaxis of 
autopsy personnel is recommended only if 
contamination of a wound or mucous mem-
brane with patient saliva or other potentially 
infectious material (e.g., neural tissue) occurs 
during the procedure.
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In the report, “Interim Results: Influenza A 
(H1N1) 2009 Monovalent and Seasonal Influenza 
Vaccination Coverage Among Health-Care Personnel 
— United States, August 2009–January 2010,” in 
the second paragraph on page 357, the second and 
third sentences should read as follows: “The panel, 
maintained by Knowledge Networks, Inc., consists 
of persons recruited using address-based sampling 
and random-digit–dialing sampling methodology. 
For the random-digit–dialing sampling, Knowledge 
Networks uses quality standards comparable to 
those of the National Immunization Survey.” In 
addition, the link in the footnote for that paragraph 
should be: http://www.knowledgenetworks.com/
ganp/docs/knowledgepanel(r)-design-summary-
description.pdf. In the first paragraph on p. 360, 
the second sentence of the paragraph should read as 
follows: “An employer recommendation was associ-
ated with an almost twofold higher coverage rate for 
seasonal influenza vaccination compared with the 
rate among HCP whose employers neither required 
nor recommended seasonal vaccination (relative 
risk [RR] = 1.7; p<0.001); an employer require-
ment was associated with a rate almost threefold 
higher (RR = 2.6; p<0.001).” Finally, in Table 2 on 
p. 361, the percentage receiving seasonal influenza 
vaccine among facilities that did not have a policy 
that required or recommended such vaccination 
should read 37.8%, with a 95% confidence interval 
of (27.9–47.7).
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TABLE I. Provisional cases of infrequently reported notifiable diseases (<1,000 cases reported during the preceding year) — United States, week ending 









Total cases reported 
for previous years States reporting cases 
during current week (No.)2009 2008 2007 2006 2005
Anthrax — — — 1 — 1 1 —
Botulism, total — 10 2 101 145 144 165 135
 foodborne — — 0 11 17 32 20 19
 infant — 9 2 66 109 85 97 85
 other (wound and unspecified) — 1 1 24 19 27 48 31
Brucellosis 2 17 2 117 80 131 121 120 TX (2)
Chancroid 1 18 1 46 25 23 33 17 FL (1)
Cholera — — 0 9 5 7 9 8
Cyclosporiasis§ 1 18 1 132 139 93 137 543 FL (1)
Diphtheria — — — — — — — —
Domestic arboviral diseases § ,¶:
 California serogroup virus disease — — 0 56 62 55 67 80
 Eastern equine encephalitis virus disease — — — 4 4 4 8 21
 Powassan virus disease — — 0 6 2 7 1 1
 St. Louis encephalitis virus disease — — 0 12 13 9 10 13
 Western equine encephalitis virus disease — — — — — — — —
Haemophilus influenzae,** invasive disease (age <5 yrs):
 serotype b — 2 0 27 30 22 29 9
 nonserotype b — 42 5 217 244 199 175 135
 unknown serotype 4 66 4 234 163 180 179 217 NYC (1), PA (1), TN (2)
Hansen disease§ — 10 1 76 80 101 66 87
Hantavirus pulmonary syndrome§ — 1 0 14 18 32 40 26
Hemolytic uremic syndrome, postdiarrheal§ 2 26 3 232 330 292 288 221 CO (1), OR (1)
HIV infection, pediatric (age <13 yrs)†† — — 2 — — — — 380
Influenza-associated pediatric mortality§,§§ 1 44 3 360 90 77 43 45 FL (1)
Listeriosis 1 115 10 801 759 808 884 896 WA (1)
Measles¶¶ — 7 3 65 140 43 55 66
Meningococcal disease, invasive***:
 A, C, Y, and W-135 2 65 9 291 330 325 318 297 MN (1), FL (1)
 serogroup B — 28 4 150 188 167 193 156
 other serogroup 1 4 1 23 38 35 32 27 NV (1)
 unknown serogroup 11 107 17 474 616 550 651 765 NY (1), MI (1), MO (2), FL (2), KY (1), CA (4)
Mumps 16 700 69 1,884 454 800 6,584 314 NY (14), FL (1), CA (1)
Novel influenza A virus infections††† — — 0 43,771 2 4 NN NN
Plague — — — 8 3 7 17 8
Poliomyelitis, paralytic — — — — — — — 1
Polio virus Infection, nonparalytic§ — — — — — — NN NN
Psittacosis§ — 2 0 9 8 12 21 16
Q fever, total§,§§§ — 13 2 98 120 171 169 136
 acute — 9 1 80 106 — — —
 chronic — 4 — 18 14 — — —
Rabies, human — — 0 4 2 1 3 2
Rubella¶¶¶ — 1 0 3 16 12 11 11
Rubella, congenital syndrome — — 0 1 — — 1 1
SARS-CoV§,**** — — — — — — — —
Smallpox§ — — — — — — — —
Streptococcal toxic-shock syndrome§ — 31 5 149 157 132 125 129
Syphilis, congenital (age <1 yr) — 23 8 353 431 430 349 329
Tetanus — — 0 17 19 28 41 27
Toxic-shock syndrome (staphylococcal)§ — 21 2 74 71 92 101 90
Trichinellosis — — 0 11 39 5 15 16
Tularemia — 2 0 90 123 137 95 154
Typhoid fever 2 69 6 354 449 434 353 324 FL (1), CA (1)
Vancomycin-intermediate Staphylococcus aureus§ — 13 1 76 63 37 6 2
Vancomycin-resistant Staphylococcus aureus§ — — 0 — — 2 1 3
Vibriosis (noncholera Vibrio species infections)§ 2 27 2 719 588 549 NN NN TX (1), CA (1)
Viral Hemorrhagic Fever†††† — — — NN NN NN NN NN
Yellow fever — — — — — — — —
See Table I footnotes on next page.
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Notifiable Disease Data Team and 122 Cities Mortality Data Team
 Patsy A. Hall-Baker
Deborah A. Adams  Rosaline Dhara
Willie J. Anderson  Pearl C. Sharp
Jose Aponte  Michael S. Wodajo
Lenee Blanton
* Ratio of current 4-week total to mean of 15 4-week totals (from previous, comparable, and subsequent 4-week periods for the 
past 5 years). The point where the hatched area begins is based on the mean and two standard deviations of these 4-week 
totals.
FIGURE I. Selected notifiable disease reports, United States, comparison of provisional 4-week 


























TABLE I. (Continued) Provisional cases of infrequently reported notifiable diseases (<1,000 cases reported during the preceding year) — United States, week ending 
April 3, 2010 (13th week)*
—: No reported cases. N: Not reportable. NN: Not Nationally Notifiable Cum: Cumulative year-to-date counts.
 * Incidence data for reporting years 2009 and 2010 are provisional, whereas data for 2005 through 2008 are finalized.
 † Calculated by summing the incidence counts for the current week, the 2 weeks preceding the current week, and the 2 weeks following the current week, for a total of 5 preceding years. 
Additional information is available at http://www.cdc.gov/epo/dphsi/phs/files/5yearweeklyaverage.pdf.
 § Not reportable in all states. Data from states where the condition is not reportable are excluded from this table, except starting in 2007 for the domestic arboviral diseases and influenza-
associated pediatric mortality, and in 2003 for SARS-CoV. Reporting exceptions are available at http://www.cdc.gov/epo/dphsi/phs/infdis.htm.
 ¶ Includes both neuroinvasive and nonneuroinvasive. Updated weekly from reports to the Division of Vector-Borne Infectious Diseases, National Center for Zoonotic, Vector-Borne, and 
Enteric Diseases (ArboNET Surveillance). Data for West Nile virus are available in Table II.
 ** Data for H. influenzae (all ages, all serotypes) are available in Table II.
 †† Updated monthly from reports to the Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. Implementation of HIV reporting influences 
the number of cases reported. Updates of pediatric HIV data have been temporarily suspended until upgrading of the national HIV/AIDS surveillance data management system is 
completed. Data for HIV/AIDS, when available, are displayed in Table IV, which appears quarterly.
 §§ Updated weekly from reports to the Influenza Division, National Center for Immunization and Respiratory Diseases. Since April 26, 2009, a total of 280 influenza-associated pediatric 
deaths associated with 2009 influenza A (H1N1) virus infection have been reported. Since August 30, 2009, a total of 270 influenza-associated pediatric deaths occurring during the 
2009–10 influenza season have been reported. A total of 133 influenza-associated pediatric deaths occurring during the 2008-09 influenza season have been reported.
 ¶¶ No measles cases were reported for the current week.
 *** Data for meningococcal disease (all serogroups) are available in Table II.
 ††† CDC discontinued reporting of individual confirmed and probable cases of 2009 pandemic influenza A (H1N1) virus infections on July 24, 2009. CDC will report the total number of 2009 
pandemic influenza A (H1N1) hospitalizations and deaths weekly on the CDC H1N1 influenza website (http://www.cdc.gov/h1n1flu). In addition, three cases of novel influenza A virus 
infections, unrelated to the 2009 pandemic influenza A (H1N1) virus, were reported to CDC during 2009.
 §§§ In 2009, Q fever acute and chronic reporting categories were recognized as a result of revisions to the Q fever case definition. Prior to that time, case counts were not differentiated with 
respect to acute and chronic Q fever cases.
 ¶¶¶ No rubella cases were reported for the current week.
 **** Updated weekly from reports to the Division of Viral and Rickettsial Diseases, National Center for Zoonotic, Vector-Borne, and Enteric Diseases.
 †††† There were no cases of Viral Hemorrhagic Fever during week one. See Table II for Dengue Hemorrhagic Fever.
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TABLE II. Provisional cases of selected notifiable diseases, United States, weeks ending April 3, 2010, and April 4, 2009 (13th week)*
Reporting area
Chlamydia trachomatis infection Cryptosporidiosis
Current  
week






Previous 52 weeks Cum  
2010
Cum  
2009Med Max Med Max
United States 8,689 22,977 27,364 221,805 317,519 48 117 261 1,053 1,073
New England 464 734 1,399 7,284 10,056 — 6 24 56 100
Connecticut — 213 736 859 2,788 — 0 18 18 40
Maine† 39 49 75 636 665 — 1 4 14 4
Massachusetts 358 374 767 4,515 5,076 — 1 15 — 34
New Hampshire 2 38 60 158 549 — 1 5 5 12
Rhode Island† 47 67 244 807 694 — 0 8 5 1
Vermont† 18 24 63 309 284 — 1 9 14 9
Mid. Atlantic 2,400 3,076 4,435 38,695 40,098 5 14 38 111 124
New Jersey 270 444 601 4,085 6,693 — 0 5 — 7
New York (Upstate) 539 618 2,415 7,534 7,291 2 3 16 22 35
New York City 1,233 1,184 2,289 16,755 15,233 — 1 5 7 23
Pennsylvania 358 824 1,019 10,321 10,881 3 9 19 82 59
E.N. Central 597 3,459 4,066 22,417 51,947 7 29 55 226 267
Illinois — 1,007 1,428 146 15,516 — 3 8 29 29
Indiana — 383 694 685 5,896 — 4 10 14 60
Michigan 480 880 1,374 12,468 12,726 1 6 11 68 55
Ohio 117 769 1,014 6,324 12,677 6 8 16 73 58
Wisconsin — 385 480 2,794 5,132 — 9 24 42 65
W.N. Central 17 1,311 1,715 13,947 18,187 7 19 59 144 125
Iowa 12 176 252 2,306 2,563 1 3 13 33 33
Kansas 5 186 573 2,070 2,625 — 2 6 11 12
Minnesota — 270 337 2,236 3,823 5 5 31 55 18
Missouri — 502 638 5,884 6,624 1 3 12 22 27
Nebraska† — 97 236 1,140 1,391 — 2 9 16 14
North Dakota — 31 92 311 407 — 0 5 1 1
South Dakota — 2 80 — 754 — 1 10 6 20
S. Atlantic 1,740 4,351 6,207 38,163 62,537 15 18 50 214 206
Delaware 36 87 180 1,035 1,260 — 0 2 1 —
District of Columbia 120 118 178 1,249 1,871 — 0 1 — 1
Florida 586 1,410 1,671 16,989 18,935 10 7 24 85 64
Georgia 2 589 1,134 480 10,432 5 5 31 87 89
Maryland† — 447 1,031 3,295 5,212 — 0 5 6 8
North Carolina — 580 1,265 — 10,694 — 0 8 11 26
South Carolina† 518 521 1,421 6,883 6,382 — 1 7 9 6
Virginia† 413 629 926 7,337 6,708 — 1 7 11 10
West Virginia 65 67 137 895 1,043 — 0 2 4 2
E.S. Central 278 1,690 2,264 18,845 23,858 3 4 10 46 33
Alabama† — 445 629 4,079 6,523 — 1 5 13 10
Kentucky — 241 642 3,323 3,147 1 2 4 15 7
Mississippi 278 468 640 4,813 6,448 — 0 3 4 4
Tennessee† — 579 734 6,630 7,740 2 1 5 14 12
W.S. Central 743 2,999 5,780 30,314 41,074 2 8 39 57 49
Arkansas† 369 266 416 3,502 3,877 — 1 5 9 5
Louisiana — 490 1,055 2,922 8,186 — 0 6 9 5
Oklahoma 374 215 2,713 4,122 1,839 1 2 9 9 10
Texas† — 2,009 3,214 19,768 27,172 1 6 28 30 29
Mountain 626 1,389 2,088 14,171 17,856 2 10 25 96 71
Arizona 131 484 742 3,147 6,005 — 0 3 3 7
Colorado 178 374 689 4,800 3,160 1 2 10 27 17
Idaho† 75 67 185 713 900 — 2 7 19 8
Montana† 21 55 79 695 848 — 1 4 14 4
Nevada† 221 168 478 2,192 2,886 1 0 2 3 —
New Mexico† — 171 257 1,007 1,874 — 2 8 15 24
Utah — 112 158 1,204 1,676 — 0 4 10 4
Wyoming† — 36 69 413 507 — 0 2 5 7
Pacific 1,824 3,449 4,820 37,969 51,906 7 13 26 103 98
Alaska — 98 129 1,142 1,394 — 0 1 1 1
California 1,493 2,603 3,912 30,455 40,336 4 7 17 63 52
Hawaii — 121 147 1,267 1,503 — 0 1 — —
Oregon — 201 468 1,367 2,674 2 3 10 25 37
Washington 331 382 525 3,738 5,999 1 1 13 14 8
American Samoa — 0 0 — — N 0 0 N N
C.N.M.I. — — — — — — — — — —
Guam — 0 1 2 — — 0 0 — —
Puerto Rico 198 126 331 1,655 1,960 N 0 0 N N
U.S. Virgin Islands — 9 21 52 108 — 0 0 — —
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Incidence data for reporting years 2009 and 2010 are provisional. Data for HIV/AIDS, AIDS, and TB, when available, are displayed in Table IV, which appears quarterly.
† Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
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TABLE II. (Continued) Provisional cases of selected notifiable diseases, United States, weeks ending April 3, 2010, and April 4, 2009 (13th week)*
Dengue Virus Infection
Reporting area
Dengue Fever Dengue Hemorrhagic Fever†
Current  
week






Previous 52 weeks Cum  
2010
Cum  
2009Med Max Med Max
United States — 0 4 11 NN — 0 0 — NN
New England — 0 1 2 NN — 0 0 — NN
Connecticut — 0 0 — NN — 0 0 — NN
Maine§ — 0 1 2 NN — 0 0 — NN
Massachusetts — 0 0 — NN — 0 0 — NN
New Hampshire — 0 0 — NN — 0 0 — NN
Rhode Island§ — 0 0 — NN — 0 0 — NN
Vermont§ — 0 0 — NN — 0 0 — NN
Mid. Atlantic — 0 2 4 NN — 0 0 — NN
New Jersey — 0 0 — NN — 0 0 — NN
New York (Upstate) — 0 0 — NN — 0 0 — NN
New York City — 0 0 — NN — 0 0 — NN
Pennsylvania — 0 2 4 NN — 0 0 — NN
E.N. Central — 0 1 1 NN — 0 0 — NN
Illinois — 0 0 — NN — 0 0 — NN
Indiana — 0 0 — NN — 0 0 — NN
Michigan — 0 0 — NN — 0 0 — NN
Ohio — 0 1 1 NN — 0 0 — NN
Wisconsin — 0 0 — NN — 0 0 — NN
W.N. Central — 0 0 — NN — 0 0 — NN
Iowa — 0 0 — NN — 0 0 — NN
Kansas — 0 0 — NN — 0 0 — NN
Minnesota — 0 0 — NN — 0 0 — NN
Missouri — 0 0 — NN — 0 0 — NN
Nebraska§ — 0 0 — NN — 0 0 — NN
North Dakota — 0 0 — NN — 0 0 — NN
South Dakota — 0 0 — NN — 0 0 — NN
S. Atlantic — 0 1 1 NN — 0 0 — NN
Delaware — 0 0 — NN — 0 0 — NN
District of Columbia — 0 0 — NN — 0 0 — NN
Florida — 0 0 — NN — 0 0 — NN
Georgia — 0 1 1 NN — 0 0 — NN
Maryland§ — 0 0 — NN — 0 0 — NN
North Carolina — 0 0 — NN — 0 0 — NN
South Carolina§ — 0 0 — NN — 0 0 — NN
Virginia§ — 0 0 — NN — 0 0 — NN
West Virginia — 0 0 — NN — 0 0 — NN
E.S. Central — 0 0 — NN — 0 0 — NN
Alabama§ — 0 0 — NN — 0 0 — NN
Kentucky — 0 0 — NN — 0 0 — NN
Mississippi — 0 0 — NN — 0 0 — NN
Tennessee§ — 0 0 — NN — 0 0 — NN
W.S. Central — 0 0 — NN — 0 0 — NN
Arkansas§ — 0 0 — NN — 0 0 — NN
Louisiana — 0 0 — NN — 0 0 — NN
Oklahoma — 0 0 — NN — 0 0 — NN
Texas§ — 0 0 — NN — 0 0 — NN
Mountain — 0 1 1 NN — 0 0 — NN
Arizona — 0 0 — NN — 0 0 — NN
Colorado — 0 0 — NN — 0 0 — NN
Idaho§ — 0 0 — NN — 0 0 — NN
Montana§ — 0 0 — NN — 0 0 — NN
Nevada§ — 0 0 — NN — 0 0 — NN
New Mexico§ — 0 1 1 NN — 0 0 — NN
Utah — 0 0 — NN — 0 0 — NN
Wyoming§ — 0 0 — NN — 0 0 — NN
Pacific — 0 2 2 NN — 0 0 — NN
Alaska — 0 0 — NN — 0 0 — NN
California — 0 0 — NN — 0 0 — NN
Hawaii — 0 0 — NN — 0 0 — NN
Oregon — 0 0 — NN — 0 0 — NN
Washington — 0 2 2 NN — 0 0 — NN
American Samoa — 0 0 — NN — 0 0 — NN
C.N.M.I. — — — — NN — — — — NN
Guam — 0 0 — NN — 0 0 — NN
Puerto Rico — 0 0 — NN — 0 0 — NN
U.S. Virgin Islands — 0 0 — NN — 0 0 — NN
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Incidence data for reporting years 2009 and 2010 are provisional.
† DHF includes cases that meet criteria for dengue shock syndrome (DSS), a more severe form of DHF.
§ Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
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TABLE II. (Continued) Provisional cases of selected notifiable diseases, United States, weeks ending April 3, 2010, and April 4, 2009 (13th week)*
Ehrlichiosis/Anaplasmosis†
Reporting area
Ehrlichia chaffeensis Anaplasma phagocytophilum Undetermined
Current 
week












Previous 52 weeks Cum 
2010
Cum 
2009Med Max Med Max Med Max
United States — 11 57 25 40 — 13 66 8 23 — 2 13 3 4
New England — 0 4 1 3 — 2 21 4 12 — 0 2 — —
Connecticut — 0 0 — — — 0 11 — — — 0 1 — —
Maine§ — 0 1 1 — — 0 3 2 — — 0 0 — —
Massachusetts — 0 0 — — — 0 0 — — — 0 0 — —
New Hampshire — 0 1 — — — 0 3 — 1 — 0 1 — —
Rhode Island§ — 0 4 — 3 — 0 20 2 11 — 0 1 — —
Vermont§ — 0 1 — — — 0 0 — — — 0 0 — —
Mid. Atlantic — 1 15 5 7 — 3 23 1 2 — 0 2 1 —
New Jersey — 0 1 — — — 0 0 — — — 0 0 — —
New York (Upstate) — 1 15 2 3 — 3 22 1 2 — 0 1 1 —
New York City — 0 3 2 3 — 0 1 — — — 0 2 — —
Pennsylvania — 0 1 1 1 — 0 0 — — — 0 0 — —
E.N. Central — 1 8 — 2 — 3 22 1 3 — 1 9 — 1
Illinois — 0 4 — — — 0 1 — — — 0 1 — —
Indiana — 0 0 — — — 0 0 — — — 0 8 — —
Michigan — 0 0 — — — 0 0 — — — 0 0 — —
Ohio — 0 2 — 1 — 0 1 — — — 0 1 — —
Wisconsin — 0 5 — 1 — 3 22 1 3 — 0 3 — 1
W.N. Central — 2 23 1 2 — 0 44 — — — 0 5 1 —
Iowa — 0 0 — — — 0 0 — — — 0 0 — —
Kansas — 0 2 — — — 0 0 — — — 0 0 — —
Minnesota — 0 3 — 2 — 0 44 — — — 0 5 — —
Missouri — 1 22 1 — — 0 2 — — — 0 4 1 —
Nebraska§ — 0 1 — — — 0 1 — — — 0 0 — —
North Dakota — 0 0 — — — 0 0 — — — 0 0 — —
South Dakota — 0 0 — — — 0 0 — — — 0 0 — —
S. Atlantic — 4 19 17 21 — 0 2 2 5 — 0 2 1 —
Delaware — 0 2 1 1 — 0 1 — — — 0 0 — —
District of Columbia — 0 0 — — — 0 0 — — — 0 0 — —
Florida — 0 1 1 2 — 0 1 — — — 0 0 — —
Georgia — 0 2 3 4 — 0 1 1 1 — 0 0 — —
Maryland§ — 1 4 5 4 — 0 1 — 1 — 0 1 — —
North Carolina — 0 4 7 9 — 0 1 1 3 — 0 0 — —
South Carolina§ — 0 1 — 1 — 0 0 — — — 0 0 — —
Virginia§ — 1 13 — — — 0 1 — — — 0 2 1 —
West Virginia — 0 1 — — — 0 0 — — — 0 0 — —
E.S. Central — 1 11 — 3 — 0 1 — 1 — 0 5 — 3
Alabama§ — 0 3 — — — 0 1 — — — 0 0 — —
Kentucky — 0 2 — — — 0 0 — — — 0 1 — —
Mississippi — 0 0 — — — 0 0 — — — 0 0 — —
Tennessee§ — 1 10 — 3 — 0 1 — 1 — 0 5 — 3
W.S. Central — 0 9 1 1 — 0 1 — — — 0 0 — —
Arkansas§ — 0 5 — — — 0 0 — — — 0 0 — —
Louisiana — 0 0 — — — 0 0 — — — 0 0 — —
Oklahoma — 0 8 — 1 — 0 1 — — — 0 0 — —
Texas§ — 0 2 1 — — 0 1 — — — 0 0 — —
Mountain — 0 0 — — — 0 0 — — — 0 1 — —
Arizona — 0 0 — — — 0 0 — — — 0 1 — —
Colorado — 0 0 — — — 0 0 — — — 0 0 — —
Idaho§ — 0 0 — — — 0 0 — — — 0 0 — —
Montana§ — 0 0 — — — 0 0 — — — 0 0 — —
Nevada§ — 0 0 — — — 0 0 — — — 0 0 — —
New Mexico§ — 0 0 — — — 0 0 — — — 0 0 — —
Utah — 0 0 — — — 0 0 — — — 0 0 — —
Wyoming§ — 0 0 — — — 0 0 — — — 0 0 — —
Pacific — 0 1 — 1 — 0 0 — — — 0 0 — —
Alaska — 0 0 — — — 0 0 — — — 0 0 — —
California — 0 1 — 1 — 0 0 — — — 0 0 — —
Hawaii — 0 0 — — — 0 0 — — — 0 0 — —
Oregon — 0 0 — — — 0 0 — — — 0 0 — —
Washington — 0 0 — — — 0 0 — — — 0 0 — —
American Samoa — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I. — — — — — — — — — — — — — — —
Guam — 0 0 — — — 0 0 — — — 0 0 — —
Puerto Rico — 0 0 — — — 0 0 — — — 0 0 — —
U.S. Virgin Islands — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Incidence data for reporting years 2009 and 2010 are provisional.
† Cumulative total E. ewingii cases reported as of this week = 0.
§ Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
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TABLE II. (Continued) Provisional cases of selected notifiable diseases, United States, weeks ending April 3, 2010, and April 4, 2009 (13th week)*
Reporting area
Giardiasis Gonorrhea
Haemophilus influenzae, invasive†  
All ages, all serotypes
Current 
week












Previous 52 weeks Cum 
2010
Cum 
2009Med Max Med Max Med Max
United States 186 335 602 3,432 3,785 1,819 5,396 6,892 49,486 76,597 32 55 144 676 888
New England 3 29 65 164 321 40 91 189 864 1,237 4 3 19 13 44
Connecticut — 6 15 51 65 — 45 122 245 545 4 0 13 4 10
Maine§ 2 4 13 43 48 5 3 11 61 34 — 0 2 1 6
Massachusetts — 12 36 — 133 27 39 81 447 536 — 1 8 — 23
New Hampshire — 3 12 24 28 1 2 6 32 29 — 0 2 4 4
Rhode Island§ — 1 6 10 11 7 6 19 70 82 — 0 2 3 —
Vermont§ 1 4 14 36 36 — 1 5 9 11 — 0 1 1 1
Mid. Atlantic 35 60 103 555 742 399 616 915 7,798 7,814 5 12 27 165 142
New Jersey — 0 12 — 113 44 94 134 1,009 1,244 — 2 7 19 20
New York (Upstate) 21 24 81 250 258 94 100 397 1,158 1,337 1 4 19 47 35
New York City 4 15 28 148 209 214 220 417 3,181 2,810 2 2 11 29 23
Pennsylvania 10 15 37 157 162 47 197 275 2,450 2,423 2 4 10 70 64
E.N. Central 17 44 75 496 577 161 1,065 1,419 6,116 16,145 3 9 29 88 210
Illinois — 11 21 94 125 — 323 417 48 4,815 — 3 11 23 42
Indiana N 0 7 N N — 107 209 227 1,958 — 1 5 14 21
Michigan 5 13 25 149 152 132 253 503 3,468 4,144 — 0 4 8 8
Ohio 12 16 28 204 187 29 258 361 1,800 3,891 3 2 6 30 30
Wisconsin — 8 17 49 113 — 89 146 573 1,337 — 2 21 13 109
W.N. Central 17 25 156 257 282 2 271 361 2,708 3,879 3 2 21 42 47
Iowa 6 6 15 63 64 — 30 46 318 417 — 0 0 — —
Kansas — 3 14 50 35 2 41 85 375 699 — 0 2 4 6
Minnesota — 0 135 — 2 — 41 64 333 597 — 0 17 12 11
Missouri 9 9 27 80 121 — 122 172 1,423 1,700 3 1 6 20 18
Nebraska§ 2 4 9 55 36 — 22 54 239 355 — 0 3 3 9
North Dakota — 0 8 3 3 — 2 14 20 16 — 0 2 3 3
South Dakota — 0 5 6 21 — 1 14 — 95 — 0 0 — —
S. Atlantic 60 72 107 893 880 489 1,307 1,790 10,589 18,374 9 13 31 170 231
Delaware — 1 3 9 5 6 18 37 234 214 — 0 1 2 1
District of Columbia — 0 2 5 13 47 45 88 483 748 — 0 1 — 1
Florida 38 36 59 438 466 198 403 476 4,570 5,365 7 4 10 50 76
Georgia 12 11 67 223 199 1 200 415 204 3,509 1 3 9 43 52
Maryland§ 4 5 12 67 65 — 123 241 933 1,434 1 1 6 10 27
North Carolina N 0 0 N N — 197 377 — 3,541 — 0 17 17 20
South Carolina§ 2 2 8 25 27 117 161 412 2,001 1,876 — 1 7 27 15
Virginia§ 4 9 36 117 94 109 161 272 2,047 1,539 — 1 5 16 28
West Virginia — 1 5 9 11 11 8 18 117 148 — 0 5 5 11
E.S. Central — 7 22 52 93 82 471 649 5,092 6,951 3 3 12 38 52
Alabama§ — 4 13 26 47 — 131 187 1,148 1,939 — 0 4 4 14
Kentucky N 0 0 N N — 66 156 894 897 — 0 5 4 5
Mississippi N 0 0 N N 82 140 198 1,356 1,983 — 0 2 3 3
Tennessee§ — 4 18 26 46 — 151 206 1,694 2,132 3 2 10 27 30
W.S. Central — 7 19 75 80 227 887 1,553 8,036 11,822 3 2 10 38 36
Arkansas§ — 3 9 21 25 120 84 139 990 1,165 — 0 3 4 8
Louisiana — 1 7 29 40 — 156 343 910 2,660 — 0 2 7 7
Oklahoma — 3 10 25 15 107 64 613 1,087 618 3 1 7 25 20
Texas§ N 0 0 N N — 562 951 5,049 7,379 — 0 2 2 1
Mountain 18 29 61 363 292 74 163 255 1,606 2,269 1 5 15 94 83
Arizona 1 4 11 37 42 23 58 108 390 670 — 1 9 36 31
Colorado 13 9 26 172 87 13 40 99 595 688 1 1 6 25 22
Idaho§ 4 4 10 51 29 4 2 8 22 25 — 0 1 2 1
Montana§ — 2 11 28 24 2 1 6 34 26 — 0 1 — 1
Nevada§ — 1 10 15 7 32 26 94 376 523 — 0 2 4 6
New Mexico§ — 1 8 14 26 — 21 36 134 236 — 1 5 13 12
Utah — 5 13 32 62 — 5 13 48 88 — 1 4 9 10
Wyoming§ — 1 5 14 15 — 1 7 7 13 — 0 2 5 —
Pacific 36 53 159 577 518 345 531 626 6,677 8,106 1 2 9 28 43
Alaska — 2 7 21 16 — 20 36 282 218 — 0 3 8 3
California 23 33 60 364 375 291 439 545 5,656 6,732 — 0 4 — 11
Hawaii — 0 2 — 6 — 13 24 163 151 — 0 3 — 16
Oregon 4 9 18 119 80 — 18 43 106 318 1 1 4 18 12
Washington 9 7 106 73 41 54 39 64 470 687 — 0 4 2 1
American Samoa — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I. — — — — — — — — — — — — — — —
Guam — 0 0 — — — 0 0 — — — 0 0 — —
Puerto Rico — 2 10 2 39 2 4 24 57 50 — 0 1 1 —
U.S. Virgin Islands — 0 0 — — — 2 7 8 35 N 0 0 N N
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Incidence data for reporting years 2009 and 2010 are provisional.
† Data for H. influenzae (age <5 yrs for serotype b, nonserotype b, and unknown serotype) are available in Table I.
§ Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
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TABLE II. (Continued) Provisional cases of selected notifiable diseases, United States, weeks ending April 3, 2010, and April 4, 2009 (13th week)*

















Previous 52 weeks Cum 
2010
Cum 
2009Med Max Med Max Med Max
United States 10 36 61 314 473 26 56 121 579 939 7 16 43 163 221
New England — 2 5 12 28 — 1 4 9 14 — 1 5 6 14
Connecticut — 0 2 7 7 — 0 3 3 3 — 1 4 6 10
Maine† — 0 1 1 1 — 0 2 4 3 — 0 1 — —
Massachusetts — 1 4 — 15 — 0 2 — 7 — 0 1 — 3
New Hampshire — 0 1 — 2 — 0 2 2 1 — 0 0 — —
Rhode Island† — 0 4 4 3 — 0 0 — — — 0 0 — —
Vermont† — 0 1 — — — 0 0 — — — 0 0 — 1
Mid. Atlantic — 4 10 46 62 1 5 16 55 103 1 2 7 15 21
New Jersey — 0 5 3 16 — 1 6 9 25 — 0 1 — 2
New York (Upstate) — 1 3 12 12 — 1 5 12 17 — 1 4 11 8
New York City — 2 5 18 17 1 1 5 19 22 — 0 0 — —
Pennsylvania — 1 6 13 17 — 2 6 15 39 1 0 4 4 11
E.N. Central — 4 19 38 77 2 7 15 77 137 — 4 12 35 51
Illinois — 2 13 8 29 — 1 7 11 24 — 0 1 — 3
Indiana — 0 4 2 6 — 1 5 10 21 — 0 4 4 2
Michigan — 1 4 13 21 — 2 6 28 36 — 3 8 30 33
Ohio — 0 4 10 14 2 1 5 28 42 — 0 3 1 12
Wisconsin — 0 2 5 7 — 0 3 — 14 — 0 2 — 1
W.N. Central 1 1 7 10 20 1 2 14 39 34 — 0 10 6 5
Iowa — 0 3 4 2 — 0 3 5 9 — 0 4 — 3
Kansas — 0 2 3 2 — 0 2 2 2 — 0 0 — 1
Minnesota — 0 7 — 5 — 0 13 2 6 — 0 9 1 —
Missouri — 0 2 2 5 1 1 5 22 10 — 0 2 4 —
Nebraska† 1 0 3 1 6 — 0 2 8 6 — 0 1 — 1
North Dakota — 0 1 — — — 0 0 — — — 0 1 — —
South Dakota — 0 1 — — — 0 1 — 1 — 0 1 1 —
S. Atlantic 1 8 14 71 115 12 15 35 169 299 1 3 12 37 48
Delaware — 0 1 3 — U 0 0 U U U 0 0 U U
District of Columbia U 0 0 U U U 0 0 U U U 0 0 U U
Florida 1 3 9 28 59 8 5 13 70 91 1 1 4 13 6
Georgia — 1 4 9 17 3 3 7 40 50 — 0 2 1 11
Maryland† — 0 3 2 14 — 1 6 17 37 — 1 3 6 13
North Carolina — 0 7 8 12 — 0 12 2 87 — 0 10 9 6
South Carolina† — 1 4 13 7 — 1 4 9 5 — 0 1 — —
Virginia† — 1 3 7 6 1 2 13 23 15 — 0 2 4 5
West Virginia — 0 2 1 — — 0 19 8 14 — 0 3 4 7
E.S. Central — 1 3 11 11 2 7 13 74 101 1 2 5 23 34
Alabama† — 0 2 3 1 — 1 5 18 31 — 0 2 1 4
Kentucky — 0 2 5 1 — 2 6 26 20 1 1 5 20 18
Mississippi — 0 1 — 5 — 0 3 4 7 — 0 0 — —
Tennessee† — 0 2 3 4 2 2 6 26 43 — 0 3 2 12
W.S. Central — 3 18 33 45 6 9 26 61 130 2 1 6 12 13
Arkansas† — 0 2 — 4 — 1 4 2 12 — 0 1 — 1
Louisiana — 0 1 1 2 — 0 3 12 16 — 0 1 1 3
Oklahoma — 0 3 — 1 2 2 8 10 24 2 0 4 5 1
Texas† — 3 18 32 38 4 6 20 37 78 — 0 4 6 8
Mountain 3 3 9 38 29 — 2 5 21 41 1 1 4 10 18
Arizona 2 1 5 25 13 — 0 3 8 19 — 0 0 — —
Colorado — 1 5 6 7 — 0 2 1 9 — 0 3 1 10
Idaho† — 0 1 2 — — 0 2 1 1 1 0 2 4 1
Montana† — 0 1 — 2 — 0 1 — — — 0 0 — —
Nevada† 1 0 2 4 — — 0 3 8 5 — 0 1 1 —
New Mexico† — 0 1 1 4 — 0 1 1 4 — 0 1 2 5
Utah — 0 2 — 3 — 0 1 2 3 — 0 1 2 2
Wyoming† — 0 1 — — — 0 2 — — — 0 0 — —
Pacific 5 5 16 55 86 2 5 29 74 80 1 1 7 19 17
Alaska — 0 1 — 2 — 0 1 1 — — 0 2 — —
California 5 4 15 47 68 1 4 17 55 62 — 1 4 5 9
Hawaii — 0 2 — 4 — 0 1 — 1 — 0 0 — —
Oregon — 0 2 4 5 1 1 4 12 10 — 0 3 9 3
Washington — 0 4 4 7 — 0 12 6 7 1 0 7 5 5
American Samoa — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I. — — — — — — — — — — — — — — —
Guam — 0 1 1 — — 1 5 8 — — 0 3 4 —
Puerto Rico — 0 2 2 10 — 0 5 4 7 — 0 0 — —
U.S. Virgin Islands — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Incidence data for reporting years 2009 and 2010 are provisional.
† Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
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TABLE II. (Continued) Provisional cases of selected notifiable diseases, United States, weeks ending April 3, 2010, and April 4, 2009 (13th week)*
Reporting area
Legionellosis Lyme disease Malaria
Current 
week












Previous 52 weeks Cum 
2010
Cum 
2009Med Max Med Max Med Max
United States 21 57 167 398 417 60 401 2,133 1,622 2,311 7 22 76 234 238
New England — 2 18 8 19 5 90 558 146 450 — 1 4 1 9
Connecticut — 0 5 3 5 — 0 0 — — — 0 3 — —
Maine† — 0 3 — — 5 12 76 54 29 — 0 1 — —
Massachusetts — 1 9 — 13 — 41 395 — 291 — 0 3 — 8
New Hampshire — 0 2 1 — — 19 93 74 106 — 0 1 1 —
Rhode Island† — 0 4 3 — — 1 28 4 2 — 0 1 — —
Vermont† — 0 1 1 1 — 5 42 14 22 — 0 1 — 1
Mid. Atlantic 5 16 72 86 109 41 209 1,143 931 1,115 1 7 13 59 49
New Jersey — 1 13 — 18 — 41 389 142 377 — 0 1 — —
New York (Upstate) 1 5 29 29 34 33 52 430 217 254 — 1 4 16 14
New York City — 3 19 20 10 — 5 32 1 46 1 4 12 32 29
Pennsylvania 4 6 25 37 47 8 107 652 571 438 — 1 4 11 6
E.N. Central 2 10 39 73 91 — 24 223 54 120 — 3 11 19 31
Illinois — 1 10 7 9 — 1 11 — 2 — 1 5 6 10
Indiana — 1 5 4 13 — 1 7 7 5 — 0 4 1 5
Michigan 1 3 13 16 14 — 1 9 1 1 — 0 3 3 5
Ohio 1 5 17 44 42 — 1 5 5 3 — 1 6 9 9
Wisconsin — 1 5 2 13 — 20 205 41 109 — 0 1 — 2
W.N. Central 1 2 14 13 9 4 5 251 7 25 — 1 8 14 9
Iowa — 0 2 — 4 — 0 14 — 6 — 0 1 2 4
Kansas — 0 1 1 2 — 0 2 1 4 — 0 1 3 1
Minnesota 1 0 13 4 — 4 0 251 4 14 — 0 8 3 1
Missouri — 1 5 5 1 — 0 1 1 — — 0 1 2 3
Nebraska† — 0 2 2 1 — 0 3 1 — — 0 2 4 —
North Dakota — 0 1 1 1 — 0 0 — — — 0 1 — —
South Dakota — 0 1 — — — 0 0 — 1 — 0 1 — —
S. Atlantic 9 11 22 85 89 8 68 253 415 560 5 6 16 70 96
Delaware — 0 5 3 — — 13 65 113 105 — 0 1 1 1
District of Columbia — 0 2 — 1 — 0 5 1 2 — 0 1 1 5
Florida 3 4 10 35 38 2 2 11 16 7 3 2 7 37 25
Georgia 1 1 4 10 17 — 0 5 1 13 — 1 5 2 15
Maryland† 3 3 12 19 14 4 29 134 171 331 2 1 13 13 28
North Carolina — 0 5 1 13 — 0 14 12 14 — 0 3 5 13
South Carolina† — 0 2 1 1 — 1 3 4 3 — 0 1 1 1
Virginia† 2 1 6 15 5 2 11 79 81 76 — 1 5 10 7
West Virginia — 0 2 1 — — 0 33 16 9 — 0 2 — 1
E.S. Central — 2 12 21 19 — 1 4 7 4 — 0 3 4 9
Alabama† — 0 2 3 3 — 0 1 — — — 0 3 1 2
Kentucky — 1 3 6 8 — 0 1 1 — — 0 3 2 —
Mississippi — 0 2 2 — — 0 0 — — — 0 1 — —
Tennessee† — 1 9 10 8 — 1 4 6 4 — 0 1 1 7
W.S. Central — 2 8 14 17 1 4 43 5 8 — 1 30 34 5
Arkansas† — 0 1 1 1 — 0 0 — — — 0 1 1 —
Louisiana — 0 2 1 1 — 0 0 — — — 0 1 — 1
Oklahoma — 0 2 — 1 — 0 0 — — — 0 1 2 —
Texas† — 1 8 12 14 1 4 43 5 8 — 1 30 31 4
Mountain 3 3 8 26 26 — 1 4 4 5 — 0 6 7 3
Arizona 1 1 5 13 9 — 0 1 — — — 0 2 2 —
Colorado — 0 4 2 2 — 0 1 1 — — 0 3 — 1
Idaho† — 0 2 — 1 — 0 3 1 2 — 0 1 — —
Montana† — 0 1 1 4 — 0 1 — 1 — 0 3 — —
Nevada† 2 0 2 8 4 — 0 1 1 1 — 0 1 2 —
New Mexico† — 0 2 1 — — 0 1 — — — 0 0 — —
Utah — 0 4 1 6 — 0 1 1 1 — 0 1 3 2
Wyoming† — 0 2 — — — 0 1 — — — 0 0 — —
Pacific 1 4 19 72 38 1 4 10 53 24 1 2 19 26 27
Alaska — 0 0 — 1 — 0 1 1 2 — 0 1 — 1
California — 3 19 65 30 1 2 9 35 18 1 2 12 18 18
Hawaii — 0 0 — 1 N 0 0 N N — 0 0 — 1
Oregon — 0 2 — 3 — 1 4 17 4 — 0 1 2 4
Washington 1 0 5 7 3 — 0 3 — — — 0 6 6 3
American Samoa N 0 0 N N N 0 0 N N — 0 0 — —
C.N.M.I. — — — — — — — — — — — — — — —
Guam — 0 0 — — — 0 0 — — — 0 0 — —
Puerto Rico — 0 1 — — N 0 0 N N — 0 2 1 1
U.S. Virgin Islands — 0 0 — — N 0 0 N N — 0 0 — —
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Incidence data for reporting years 2009 and 2010 are provisional.
† Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
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TABLE II. (Continued) Provisional cases of selected notifiable diseases, United States, weeks ending April 3, 2010, and April 4, 2009 (13th week)*
Reporting area
Meningococcal disease, invasive† 
All groups Pertussis Rabies, animal
Current 
week












Previous 52 weeks Cum 
2010
Cum 
2009Med Max Med Max Med Max
United States 14 16 38 204 295 70 271 1,523 1,971 3,010 26 62 139 512 844
New England — 0 2 1 14 — 10 25 11 160 2 6 24 55 67
Connecticut — 0 2 — 2 — 1 4 — 7 1 1 22 22 26
Maine§ — 0 1 — 1 — 0 10 3 28 — 1 4 16 12
Massachusetts — 0 1 — 8 — 5 17 — 100 — 0 0 — —
New Hampshire — 0 1 — 1 — 1 7 2 14 — 0 3 3 6
Rhode Island§ — 0 1 — 1 — 0 8 4 5 — 0 5 1 7
Vermont§ — 0 1 1 1 — 0 1 2 6 1 1 5 13 16
Mid. Atlantic 1 2 6 15 28 11 20 40 140 248 8 11 23 146 144
New Jersey — 0 2 — 3 — 2 8 9 63 — 0 0 — —
New York (Upstate) 1 0 3 3 5 11 5 27 66 38 8 8 22 104 72
New York City — 0 2 5 4 — 0 11 — 17 — 0 11 42 1
Pennsylvania — 1 3 7 16 — 9 29 65 130 — 0 16 — 71
E.N. Central 1 2 7 27 64 24 54 100 517 692 — 2 19 6 8
Illinois — 0 4 6 15 — 11 29 59 177 — 1 9 1 2
Indiana — 0 3 7 13 — 5 15 24 91 — 0 7 — 1
Michigan 1 0 5 3 9 2 16 41 169 151 — 1 6 3 5
Ohio — 1 2 8 16 22 19 49 260 240 — 0 5 2 —
Wisconsin — 0 1 3 11 — 1 12 5 33 N 0 0 N N
W.N. Central 3 1 6 16 22 4 31 599 135 512 3 7 18 37 66
Iowa — 0 2 3 1 — 3 10 24 42 — 0 3 — 6
Kansas — 0 2 1 6 — 4 12 30 53 — 1 6 15 27
Minnesota 1 0 2 2 5 — 0 585 — 36 — 0 11 8 5
Missouri 2 0 3 8 8 3 13 47 64 320 1 1 5 3 5
Nebraska§ — 0 1 2 2 1 2 9 14 53 2 1 6 11 15
North Dakota — 0 1 — — — 0 12 — 2 — 0 7 — 3
South Dakota — 0 1 — — — 0 6 3 6 — 0 4 — 5
S. Atlantic 3 3 10 49 52 6 27 66 196 408 4 22 103 208 437
Delaware — 0 1 1 — — 0 2 — 4 — 0 0 — —
District of Columbia — 0 0 — — — 0 1 1 3 — 0 0 — —
Florida 3 1 5 24 24 5 7 29 48 105 — 0 13 34 156
Georgia — 0 2 4 7 1 4 11 43 80 — 0 72 — 88
Maryland§ — 0 1 2 1 — 3 8 34 28 — 8 15 81 65
North Carolina — 0 10 5 9 — 0 21 — 119 N 0 4 N N
South Carolina§ — 0 1 4 5 — 4 18 46 34 — 0 0 — —
Virginia§ — 0 2 8 5 — 3 15 19 32 — 10 26 76 109
West Virginia — 0 2 1 1 — 0 6 5 3 4 2 6 17 19
E.S. Central 1 0 4 7 11 3 14 30 171 171 1 1 6 3 41
Alabama§ — 0 2 1 2 — 5 19 50 32 1 0 1 3 —
Kentucky 1 0 1 3 2 — 3 15 56 80 — 0 2 — 17
Mississippi — 0 1 1 1 — 1 6 13 19 — 0 1 — —
Tennessee§ — 0 2 2 6 3 4 9 52 40 — 0 4 — 24
W.S. Central — 1 8 27 25 13 68 704 537 336 2 0 13 10 10
Arkansas§ — 0 2 2 5 — 5 30 18 39 — 0 10 6 6
Louisiana — 0 3 5 8 — 0 8 7 29 — 0 0 — —
Oklahoma — 0 7 12 2 — 0 32 3 9 2 0 13 4 4
Texas§ — 1 7 8 10 13 60 674 509 259 — 0 1 — —
Mountain 1 1 4 14 25 6 16 39 158 280 2 1 6 13 31
Arizona — 0 2 5 4 1 5 16 46 50 N 0 0 N N
Colorado — 0 3 3 9 5 3 10 26 70 — 0 0 — —
Idaho§ — 0 1 1 5 — 1 19 43 22 — 0 1 1 —
Montana§ — 0 2 1 3 — 1 6 5 5 — 0 4 — 10
Nevada§ 1 0 1 2 1 — 0 3 1 2 — 0 1 — —
New Mexico§ — 0 1 2 1 — 1 6 24 29 — 0 3 3 11
Utah — 0 1 — 1 — 2 11 12 99 — 0 2 — —
Wyoming§ — 0 2 — 1 — 0 5 1 3 2 0 4 9 10
Pacific 4 3 17 48 54 3 24 46 106 203 4 4 13 34 40
Alaska — 0 2 — 2 — 0 4 5 24 — 0 2 8 10
California 4 2 10 37 28 2 11 25 11 73 4 3 11 22 30
Hawaii — 0 1 — 1 — 0 3 — 7 — 0 0 — —
Oregon — 0 4 7 17 — 5 12 61 56 — 0 3 4 —
Washington — 0 6 4 6 1 4 39 29 43 — 0 0 — —
American Samoa — 0 0 — — — 0 0 — — N 0 0 N N
C.N.M.I. — — — — — — — — — — — — — — —
Guam — 0 0 — — — 0 0 — — — 0 0 — —
Puerto Rico — 0 1 — — — 0 0 — 1 1 1 3 15 12
U.S. Virgin Islands — 0 0 — — — 0 0 — — N 0 0 N N
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Incidence data for reporting years 2009 and 2010 are provisional.
† Data for meningococcal disease, invasive caused by serogroups A, C, Y, and W-135; serogroup B; other serogroup; and unknown serogroup are available in Table I.
§ Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
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TABLE II. (Continued) Provisional cases of selected notifiable diseases, United States, weeks ending April 3, 2010, and April 4, 2009 (13th week)*
Reporting area
Salmonellosis Shiga toxin-producing E. coli (STEC)† Shigellosis
Current 
week












Previous 52 weeks Cum 
2010
Cum 
2009Med Max Med Max Med Max
United States 263 913 1,443 5,401 8,087 22 84 174 379 720 114 278 504 2,533 3,731
New England — 31 91 129 727 — 3 30 10 89 — 4 27 18 89
Connecticut — 0 66 66 429 — 0 5 5 67 — 0 11 11 43
Maine§ — 2 7 14 23 — 0 3 — — — 0 2 2 2
Massachusetts — 20 47 — 202 — 2 7 — 11 — 3 27 — 37
New Hampshire — 3 44 24 37 — 0 3 5 9 — 0 4 3 1
Rhode Island§ — 2 12 17 24 — 0 26 — — — 0 7 1 4
Vermont§ — 1 5 8 12 — 0 3 — 2 — 0 1 1 2
Mid. Atlantic 27 98 207 659 887 — 7 22 37 76 13 44 89 381 752
New Jersey — 17 47 53 164 — 1 5 1 21 — 5 23 28 249
New York (Upstate) 13 23 77 165 200 — 3 12 16 22 4 4 19 43 42
New York City 1 21 48 186 217 — 1 5 7 18 — 8 16 66 130
Pennsylvania 13 29 66 255 306 — 2 8 13 15 9 26 63 244 331
E.N. Central 26 91 159 577 1,103 1 13 36 43 133 3 34 113 352 843
Illinois — 24 52 169 319 — 3 6 5 49 — 11 109 243 178
Indiana — 9 24 35 89 — 1 9 2 15 — 1 5 1 25
Michigan 1 16 34 128 202 1 3 8 20 19 — 3 10 33 88
Ohio 25 24 52 211 288 — 2 11 10 19 3 11 46 63 432
Wisconsin — 11 30 34 205 — 4 21 6 31 — 5 26 12 120
W.N. Central 20 43 86 359 578 4 11 39 61 67 38 35 87 635 118
Iowa — 6 16 41 79 — 2 14 9 17 — 0 5 11 31
Kansas — 6 22 55 64 — 1 5 6 6 — 3 13 38 43
Minnesota 11 11 31 101 117 1 2 17 17 19 3 1 6 14 15
Missouri 7 13 30 116 87 2 2 10 20 15 34 28 75 567 20
Nebraska§ 2 4 12 35 149 1 1 6 8 9 1 0 3 5 7
North Dakota — 0 21 4 9 — 0 3 — — — 0 2 — 1
South Dakota — 1 9 7 73 — 0 12 1 1 — 0 1 — 1
S. Atlantic 85 282 453 1,779 1,981 13 12 22 90 130 23 40 79 372 551
Delaware 3 2 9 16 7 — 0 2 — 2 — 3 10 26 5
District of Columbia — 0 3 7 15 — 0 0 — 1 — 0 1 2 5
Florida 58 133 278 857 792 9 3 7 42 38 14 10 18 143 106
Georgia 7 45 98 263 315 — 1 4 9 11 8 13 29 123 127
Maryland§ 10 15 32 137 146 2 1 6 11 19 1 4 17 20 103
North Carolina — 12 90 223 387 — 0 8 4 41 — 2 27 15 101
South Carolina§ 4 17 65 100 139 — 0 3 1 4 — 2 6 21 47
Virginia§ 3 20 68 139 153 2 3 7 23 13 — 3 15 22 52
West Virginia — 4 23 37 27 — 0 5 — 1 — 0 2 — 5
E.S. Central 6 52 113 299 455 — 4 10 22 39 2 12 46 83 202
Alabama§ — 14 39 94 149 — 1 4 9 8 — 2 9 8 55
Kentucky 1 7 18 60 93 — 1 4 2 10 2 3 25 40 25
Mississippi — 14 45 44 100 — 0 1 3 3 — 1 4 2 8
Tennessee§ 5 14 33 101 113 — 1 8 8 18 — 5 16 33 114
W.S. Central 9 105 497 300 708 — 5 41 21 40 27 49 158 381 652
Arkansas§ 2 10 25 43 84 — 1 4 5 7 — 5 15 11 59
Louisiana — 9 43 88 90 — 0 1 3 — — 1 7 18 56
Oklahoma 6 11 30 56 87 — 0 6 1 4 14 6 19 69 33
Texas§ 1 59 478 113 447 — 4 41 12 29 13 36 142 283 504
Mountain 8 52 120 429 548 — 7 28 44 78 1 17 43 122 262
Arizona 1 20 57 141 214 — 1 5 9 6 1 13 37 68 183
Colorado 5 12 33 128 117 — 2 11 7 49 — 2 6 22 25
Idaho§ — 3 10 24 31 — 1 7 7 6 — 0 1 3 —
Montana§ — 2 7 24 27 — 0 7 8 1 — 0 4 3 2
Nevada§ 2 3 11 31 31 — 0 3 1 1 — 1 7 5 22
New Mexico§ — 5 27 43 48 — 1 3 6 8 — 1 8 18 24
Utah — 5 14 24 68 — 1 11 6 6 — 0 4 3 6
Wyoming§ — 1 9 14 12 — 0 2 — 1 — 0 1 — —
Pacific 82 123 346 870 1,100 4 9 73 51 68 7 21 61 189 262
Alaska — 1 7 17 12 — 0 0 — — — 0 2 — 1
California 58 93 201 676 842 3 4 23 32 50 4 16 40 163 219
Hawaii — 5 61 — 61 — 0 2 — 3 — 0 4 — 6
Oregon 9 8 19 85 92 1 1 11 6 3 2 1 4 15 10
Washington 15 11 133 92 93 — 2 48 13 12 1 2 19 11 26
American Samoa — 1 1 1 — — 0 0 — — — 0 0 — 3
C.N.M.I. — — — — — — — — — — — — — — —
Guam — 0 0 — — — 0 0 — — — 0 0 — —
Puerto Rico — 9 39 52 133 — 0 0 — — — 0 2 — 3
U.S. Virgin Islands — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Incidence data for reporting years 2009 and 2010 are provisional.
† Includes E. coli O157:H7; Shiga toxin-positive, serogroup non-O157; and Shiga toxin-positive, not serogrouped.
§ Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
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TABLE II. (Continued) Provisional cases of selected notifiable diseases, United States, weeks ending April 3, 2010, and April 4, 2009 (13th week)*











Previous 52 weeks Cum  
2010
Cum  
2009Med Max Med Max
United States — 2 10 16 10 — 17 71 63 182
New England — 0 1 — — — 0 2 — 2
Connecticut — 0 0 — — — 0 0 — —
Maine§ — 0 0 — — — 0 2 — 1
Massachusetts — 0 1 — — — 0 1 — 1
New Hampshire — 0 0 — — — 0 1 — —
Rhode Island§ — 0 0 — — — 0 0 — —
Vermont§ — 0 1 — — — 0 0 — —
Mid. Atlantic — 0 3 3 — — 1 6 2 5
New Jersey — 0 0 — — — 0 0 — —
New York (Upstate) — 0 1 — — — 0 3 — —
New York City — 0 1 1 — — 0 4 2 4
Pennsylvania — 0 2 2 — — 0 2 — 1
E.N. Central — 0 2 — 1 — 0 7 — 10
Illinois — 0 1 — — — 0 6 — 6
Indiana — 0 2 — — — 0 2 — —
Michigan — 0 1 — 1 — 0 1 — —
Ohio — 0 0 — — — 0 4 — 4
Wisconsin — 0 0 — — — 0 1 — —
W.N. Central — 0 3 — 2 — 2 23 5 2
Iowa — 0 1 — — — 0 1 — —
Kansas — 0 1 — 1 — 0 0 — —
Minnesota — 0 1 — — — 0 1 — —
Missouri — 0 1 — — — 2 22 5 2
Nebraska§ — 0 2 — 1 — 0 1 — —
North Dakota — 0 0 — — — 0 0 — —
South Dakota — 0 0 — — — 0 0 — —
S. Atlantic — 1 8 7 5 — 5 25 37 139
Delaware — 0 1 1 — — 0 3 2 1
District of Columbia — 0 0 — — — 0 0 — —
Florida — 0 1 — — — 0 2 1 1
Georgia — 0 7 5 5 — 0 0 — —
Maryland§ — 0 1 — — — 0 3 3 10
North Carolina — 0 1 1 — — 1 24 27 113
South Carolina§ — 0 1 — — — 0 4 2 5
Virginia§ — 0 1 — — — 0 5 2 8
West Virginia — 0 0 — — — 0 1 — 1
E.S. Central — 0 2 2 1 — 4 15 2 16
Alabama§ — 0 1 — — — 1 7 1 5
Kentucky — 0 1 1 — — 0 0 — —
Mississippi — 0 0 — 1 — 0 1 — —
Tennessee§ — 0 2 1 — — 2 14 1 11
W.S. Central — 0 3 1 — — 1 25 5 6
Arkansas§ — 0 0 — — — 0 14 — 1
Louisiana — 0 0 — — — 0 1 — —
Oklahoma — 0 3 — — — 0 24 1 1
Texas§ — 0 1 1 — — 0 11 4 4
Mountain — 0 2 3 1 — 0 6 12 2
Arizona — 0 2 3 1 — 0 6 12 —
Colorado — 0 1 — — — 0 0 — —
Idaho§ — 0 0 — — — 0 1 — —
Montana§ — 0 1 — — — 0 2 — —
Nevada§ — 0 0 — — — 0 0 — —
New Mexico§ — 0 0 — — — 0 0 — 1
Utah — 0 0 — — — 0 0 — 1
Wyoming§ — 0 1 — — — 0 1 — —
Pacific — 0 1 — — — 0 0 — —
Alaska — 0 0 — — — 0 0 — —
California — 0 1 — — — 0 0 — —
Hawaii — 0 0 — — — 0 0 — —
Oregon — 0 0 — — — 0 0 — —
Washington — 0 0 — — — 0 0 — —
American Samoa — 0 0 — — — 0 0 — —
C.N.M.I. — — — — — — — — — —
Guam — 0 0 — — — 0 0 — —
Puerto Rico — 0 0 — — — 0 0 — —
U.S. Virgin Islands — 0 0 — — — 0 0 — —
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Incidence data for reporting years 2009 and 2010 are provisional.
† Illnesses with similar clinical presentation that result from Spotted fever group rickettsia infections are reported as Spotted fever rickettsioses. Rocky Mountain spotted fever (RMSF) caused 
by Rickettsia rickettsii, is the most common and well-known spotted fever.
§ Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
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TABLE II. (Continued) Provisional cases of selected notifiable diseases, United States, weeks ending April 3, 2010, and April 4, 2009 (13th week)*
Streptococcus pneumoniae,† invasive disease
Reporting area
All ages Age <5 Syphilis, primary and secondary
Current 
week












Previous 52 weeks Cum 
2010
Cum 
2009Med Max Med Max Med Max
United States 249 55 375 4,003 1,118 45 47 128 674 781 91 252 347 2,157 3,607
New England 2 1 50 110 23 — 1 23 9 22 7 6 21 87 89
Connecticut — 0 50 — — — 0 22 — — — 1 9 11 21
Maine§ 2 0 4 30 3 — 0 2 3 — 1 0 3 8 1
Massachusetts — 0 1 — 1 — 0 5 — 17 5 4 12 54 56
New Hampshire — 0 6 37 5 — 0 2 3 3 — 0 1 3 7
Rhode Island§ — 0 5 15 9 — 0 1 2 — 1 0 5 9 4
Vermont§ — 0 6 28 5 — 0 1 1 2 — 0 2 2 —
Mid. Atlantic 12 4 25 209 60 6 5 48 69 74 38 34 50 423 467
New Jersey — 0 4 18 — — 1 4 11 17 2 3 13 52 65
New York (Upstate) 5 2 12 53 27 5 2 19 40 40 3 2 11 22 24
New York City — 0 1 — 2 — 0 28 — 11 32 20 39 265 295
Pennsylvania 7 2 19 138 31 1 0 5 18 6 1 7 14 84 83
E.N. Central 15 13 69 559 229 2 8 16 113 129 — 25 53 120 341
Illinois — 0 7 37 — — 1 5 31 15 — 11 36 7 170
Indiana — 4 17 107 85 — 1 4 14 23 — 2 9 7 43
Michigan 6 1 26 192 10 — 2 5 29 21 — 3 13 50 56
Ohio 9 8 18 132 134 2 2 7 30 48 — 7 13 56 54
Wisconsin — 0 20 91 — — 1 3 9 22 — 0 3 — 18
W.N. Central 28 3 59 291 55 7 3 13 61 59 — 5 12 39 85
Iowa — 0 0 — — — 0 0 — — — 0 2 — 10
Kansas — 1 6 28 29 — 0 2 5 11 — 0 3 1 3
Minnesota 21 0 45 163 — 5 0 10 30 16 — 1 3 9 21
Missouri 6 1 8 44 22 1 1 5 19 23 — 3 8 27 49
Nebraska§ 1 0 7 48 — 1 0 2 6 2 — 0 2 2 1
North Dakota — 0 4 4 4 — 0 1 — 3 — 0 1 — 1
South Dakota — 0 2 4 — — 0 2 1 4 — 0 1 — —
S. Atlantic 91 26 135 1,190 552 15 11 26 187 208 34 62 161 527 745
Delaware — 0 3 7 8 — 0 2 — — — 0 3 1 8
District of Columbia — 0 3 12 — — 0 1 3 — — 2 8 26 47
Florida 65 14 90 614 335 10 4 19 88 73 1 19 32 182 298
Georgia 3 8 24 153 172 3 3 9 41 62 — 14 112 34 104
Maryland§ 20 0 25 160 4 2 1 7 22 27 — 6 12 41 68
North Carolina — 0 0 — — — 0 0 — — 8 9 31 129 122
South Carolina§ 3 0 25 192 — — 1 4 18 20 3 2 6 36 22
Virginia§ — 0 2 14 — — 1 3 12 22 22 6 15 78 74
West Virginia — 2 20 38 33 — 0 3 3 4 — 0 2 — 2
E.S. Central 23 4 50 390 109 1 2 9 38 46 — 20 38 171 307
Alabama§ — 0 0 — — — 0 0 — — — 6 18 34 123
Kentucky — 1 8 36 33 — 0 2 4 4 — 1 13 24 16
Mississippi — 0 5 23 3 — 0 2 5 6 — 5 17 36 50
Tennessee§ 23 2 44 331 73 1 2 7 29 36 — 7 14 77 118
W.S. Central 40 1 61 499 39 9 6 38 83 110 4 47 74 331 725
Arkansas§ 3 1 8 51 18 1 0 4 9 12 1 6 16 63 43
Louisiana — 0 8 27 21 — 0 3 8 16 — 10 27 64 246
Oklahoma 2 0 5 21 — 2 1 5 21 15 3 1 6 12 28
Texas§ 35 0 54 400 — 6 3 34 45 67 — 30 46 192 408
Mountain 32 2 67 669 49 5 5 11 100 120 — 9 18 68 124
Arizona 16 0 42 333 — 2 2 7 47 57 — 4 11 17 54
Colorado 15 0 20 185 — 2 1 4 24 22 — 2 5 28 26
Idaho§ — 0 1 4 — — 0 2 2 2 — 0 1 1 2
Montana§ — 0 1 4 — — 0 0 — — — 0 1 — —
Nevada§ — 1 4 26 15 — 0 2 3 2 — 1 10 19 24
New Mexico§ — 0 8 55 — — 0 4 12 11 — 1 4 3 12
Utah — 1 9 56 28 — 1 6 10 26 — 0 2 — 6
Wyoming§ 1 0 2 6 6 1 0 1 2 — — 0 1 — —
Pacific 6 0 14 86 2 — 0 7 14 13 8 42 61 391 724
Alaska — 0 9 38 — — 0 5 11 8 — 0 0 — —
California 6 0 10 48 — — 0 2 3 — 7 38 55 359 657
Hawaii — 0 1 — 2 — 0 2 — 5 — 0 2 8 12
Oregon — 0 0 — — — 0 0 — — — 1 5 6 9
Washington — 0 0 — — — 0 0 — — 1 2 7 18 46
American Samoa — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I. — — — — — — — — — — — — — — —
Guam — 0 0 — — — 0 0 — — — 0 0 — —
Puerto Rico — 0 0 — — — 0 0 — — 2 3 17 53 43
U.S. Virgin Islands — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Incidence data for reporting years 2009 and 2010 are provisional.
† Includes drug resistant and susceptible cases of invasive Streptococcus pneumoniae disease among children <5 years and among all ages. Case definition: Isolation of S. pneumoniae from 
a normally sterile body site (e.g., blood or cerebrospinal fluid).
§ Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
MMWR  Morbidity and Mortality Weekly Report
410 MMWR  /  April 9, 2010  /  Vol. 59  /  No. 13
TABLE II. (Continued) Provisional cases of selected notifiable diseases, United States, weeks ending April 3, 2010, and April 4, 2009 (13th week)*
West Nile virus disease†
Reporting area
Varicella (chickenpox)§ Neuroinvasive Nonneuroinvasive¶
Current 
week












Previous 52 weeks Cum 
2010
Cum 
2009Med Max Med Max Med Max
United States 153 285 634 3,488 6,622 — 1 46 2 — — 0 49 — —
New England 3 14 33 126 230 — 0 0 — — — 0 0 — —
Connecticut — 7 23 43 133 — 0 0 — — — 0 0 — —
Maine§ — 0 15 30 — — 0 0 — — — 0 0 — —
Massachusetts — 0 2 — — — 0 0 — — — 0 0 — —
New Hampshire 1 3 10 38 64 — 0 0 — — — 0 0 — —
Rhode Island§ 2 0 2 3 4 — 0 0 — — — 0 0 — —
Vermont§ — 0 4 12 29 — 0 0 — — — 0 0 — —
Mid. Atlantic 16 24 56 266 537 — 0 2 — — — 0 1 — —
New Jersey N 0 0 N N — 0 1 — — — 0 0 — —
New York (Upstate) N 0 0 N N — 0 1 — — — 0 1 — —
New York City — 0 0 — — — 0 1 — — — 0 0 — —
Pennsylvania 16 24 56 266 537 — 0 0 — — — 0 0 — —
E.N. Central 58 107 205 1,486 2,437 — 0 4 — — — 0 3 — —
Illinois 2 26 56 360 631 — 0 3 — — — 0 0 — —
Indiana§ 5 7 35 175 150 — 0 1 — — — 0 1 — —
Michigan 16 36 84 466 718 — 0 1 — — — 0 0 — —
Ohio 35 29 85 416 758 — 0 0 — — — 0 2 — —
Wisconsin — 7 57 69 180 — 0 1 — — — 0 0 — —
W.N. Central 2 9 40 102 411 — 0 5 — — — 0 11 — —
Iowa N 0 0 N N — 0 0 — — — 0 1 — —
Kansas§ — 1 19 1 92 — 0 1 — — — 0 2 — —
Minnesota — 0 0 — — — 0 1 — — — 0 1 — —
Missouri 2 6 30 84 277 — 0 2 — — — 0 1 — —
Nebraska§ N 0 0 N N — 0 2 — — — 0 6 — —
North Dakota — 0 26 15 36 — 0 0 — — — 0 1 — —
South Dakota — 0 2 2 6 — 0 3 — — — 0 2 — —
S. Atlantic 65 24 76 514 774 — 0 4 — — — 0 2 — —
Delaware§ — 0 2 2 2 — 0 0 — — — 0 0 — —
District of Columbia — 0 2 1 8 — 0 1 — — — 0 0 — —
Florida§ 23 14 57 264 468 — 0 1 — — — 0 1 — —
Georgia N 0 0 N N — 0 1 — — — 0 0 — —
Maryland§ N 0 0 N N — 0 0 — — — 0 1 — —
North Carolina N 0 0 N N — 0 0 — — — 0 0 — —
South Carolina§ — 0 33 42 118 — 0 2 — — — 0 0 — —
Virginia§ 7 0 10 77 28 — 0 2 — — — 0 0 — —
West Virginia 35 8 25 128 150 — 0 0 — — — 0 0 — —
E.S. Central 4 6 29 61 180 — 0 6 2 — — 0 4 — —
Alabama§ 4 6 27 61 179 — 0 0 — — — 0 0 — —
Kentucky N 0 0 N N — 0 1 — — — 0 0 — —
Mississippi — 0 2 — 1 — 0 5 2 — — 0 4 — —
Tennessee§ N 0 0 N N — 0 2 — — — 0 1 — —
W.S. Central — 66 261 623 1,432 — 0 19 — — — 0 6 — —
Arkansas§ — 0 23 26 41 — 0 1 — — — 0 0 — —
Louisiana — 1 7 19 20 — 0 2 — — — 0 4 — —
Oklahoma N 0 0 N N — 0 2 — — — 0 2 — —
Texas§ — 65 245 578 1,371 — 0 16 — — — 0 4 — —
Mountain 5 20 62 303 577 — 0 12 — — — 0 17 — —
Arizona — 0 0 — — — 0 4 — — — 0 2 — —
Colorado§ — 8 22 108 202 — 0 7 — — — 0 14 — —
Idaho§ N 0 0 N N — 0 3 — — — 0 5 — —
Montana§ 5 0 17 72 81 — 0 1 — — — 0 1 — —
Nevada§ N 0 0 N N — 0 2 — — — 0 1 — —
New Mexico§ — 0 12 24 82 — 0 2 — — — 0 1 — —
Utah — 7 32 98 212 — 0 1 — — — 0 1 — —
Wyoming§ — 0 1 1 — — 0 1 — — — 0 2 — —
Pacific — 1 5 7 44 — 0 12 — — — 0 12 — —
Alaska — 0 4 7 25 — 0 0 — — — 0 0 — —
California — 0 0 — — — 0 8 — — — 0 6 — —
Hawaii — 0 4 — 19 — 0 0 — — — 0 0 — —
Oregon N 0 0 N N — 0 1 — — — 0 4 — —
Washington N 0 0 N N — 0 6 — — — 0 3 — —
American Samoa N 0 0 N N — 0 0 — — — 0 0 — —
C.N.M.I. — — — — — — — — — — — — — — —
Guam — 0 0 — — — 0 0 — — — 0 0 — —
Puerto Rico 1 7 30 57 151 — 0 0 — — — 0 0 — —
U.S. Virgin Islands — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
 * Incidence data for reporting years 2009 and 2010 are provisional. Data for HIV/AIDS, AIDS, and TB, when available, are displayed in Table IV, which appears quarterly.
 † Updated weekly from reports to the Division of Vector-Borne Infectious Diseases, National Center for Zoonotic, Vector-Borne, and Enteric Diseases (ArboNET Surveillance). Data for California 
serogroup, eastern equine, Powassan, St. Louis, and western equine diseases are available in Table I.
 § Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
 ¶ Not reportable in all states. Data from states where the condition is not reportable are excluded from this table, except starting in 2007 for the domestic arboviral diseases and influenza-
associated pediatric mortality, and in 2003 for SARS-CoV. Reporting exceptions are available at http://www.cdc.gov/epo/dphsi/phs/infdis.htm.
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TABLE III. Deaths in 122 U.S. cities,* week ending April 3, 2010 (13th week)
Reporting area
All causes, by age (years)
P&I† 
Total Reporting area




Ages ≥65 45–64 25–44 1–24 <1
All  
Ages ≥65 45–64 25–44 1–24 <1
New England 548 396 113 24 11 4 54 S. Atlantic 1,321 858 327 86 33 17 87
Boston, MA 128 78 32 11 6 1 13 Atlanta, GA 169 103 46 14 5 1 14
Bridgeport, CT 48 36 12 — — — 8 Baltimore, MD 168 96 57 12 2 1 14
Cambridge, MA 22 18 3 — 1 — 3 Charlotte, NC 70 53 9 4 2 2 6
Fall River, MA 28 18 7 2 1 — 3 Jacksonville, FL 198 134 53 4 6 1 14
Hartford, CT 44 30 9 3 1 1 4 Miami, FL 106 64 26 10 6 — 7
Lowell, MA 27 19 7 1 — — — Norfolk, VA 46 30 12 1 3 — 3
Lynn, MA 3 2 1 — — — — Richmond, VA 65 39 17 6 — 3 1
New Bedford, MA 17 12 5 — — — — Savannah, GA 61 38 17 4 — 2 7
New Haven, CT 33 31 2 — — — 5 St. Petersburg, FL 54 33 12 7 2 — 5
Providence, RI 61 42 16 1 1 1 5 Tampa, FL 266 193 48 15 4 6 15
Somerville, MA — — — — — — — Washington, D.C. 106 66 27 9 3 1 1
Springfield, MA 42 34 7 — — 1 4 Wilmington, DE 12 9 3 — — — —
Waterbury, CT 18 15 3 — — — 1 E.S. Central 851 549 222 56 13 11 71
Worcester, MA 77 61 9 6 1 — 8 Birmingham, AL 171 105 47 13 3 3 17
Mid. Atlantic 2,054 1,426 450 113 31 31 109 Chattanooga, TN 51 33 15 2 1 — 2
Albany, NY 51 33 11 4 3 — 3 Knoxville, TN 82 59 16 5 2 — 7
Allentown, PA 26 19 5 2 — — 1 Lexington, KY 73 53 15 5 — — 6
Buffalo, NY 85 54 25 3 2 1 8 Memphis, TN 178 112 51 9 3 3 17
Camden, NJ 29 19 5 2 — 3 4 Mobile, AL 93 56 28 6 1 2 7
Elizabeth, NJ 50 35 13 1 — 1 4 Montgomery, AL 62 41 12 8 — 1 4
Erie, PA 41 32 7 1 1 — 4 Nashville, TN 141 90 38 8 3 2 11
Jersey City, NJ 36 25 6 4 1 — 2 W.S. Central 1,180 742 297 69 39 33 83
New York City, NY 1,186 816 271 70 14 12 51 Austin, TX 92 53 26 6 4 3 4
Newark, NJ 26 16 6 1 — 3 1 Baton Rouge, LA 62 25 17 10 6 4 —
Paterson, NJ 15 6 5 2 — 2 1 Corpus Christi, TX 63 45 17 — — 1 4
Philadelphia, PA 148 96 36 7 4 5 8 Dallas, TX 208 121 55 16 8 8 12
Pittsburgh, PA§ 44 32 10 2 — — 2 El Paso, TX 58 32 15 4 7 — 6
Reading, PA 34 29 2 3 — — 4 Fort Worth, TX U U U U U U U
Rochester, NY 83 57 19 4 1 2 4 Houston, TX 208 126 60 7 4 11 18
Schenectady, NY 19 13 4 — 2 — 1 Little Rock, AR 92 57 26 6 1 2 3
Scranton, PA 25 20 5 — — — 1 New Orleans, LA U U U U U U U
Syracuse, NY 96 76 11 4 3 2 5 San Antonio, TX 268 186 56 15 8 3 26
Trenton, NJ 20 16 3 1 — — 2 Shreveport, LA 16 14 2 — — — 2
Utica, NY 20 18 — 2 — — 2 Tulsa, OK 113 83 23 5 1 1 8
Yonkers, NY 20 14 6 — — — 1 Mountain 1,172 790 267 69 17 24 93
E.N. Central 1,914 1,313 452 91 32 26 123 Albuquerque, NM 123 79 30 9 2 3 13
Akron, OH 50 44 4 2 — — 6 Boise, ID 44 31 10 2 — 1 6
Canton, OH 34 28 6 — — — 1 Colorado Springs, CO 71 49 12 7 1 2 3
Chicago, IL 310 179 96 24 9 2 17 Denver, CO 90 62 20 1 2 5 7
Cincinnati, OH 79 46 21 7 3 2 7 Las Vegas, NV 282 190 73 12 4 3 22
Cleveland, OH 198 140 47 5 5 1 14 Ogden, UT 33 23 7 2 — 1 4
Columbus, OH 221 153 52 7 3 6 13 Phoenix, AZ 174 105 46 14 5 4 14
Dayton, OH 144 104 29 10 1 — 16 Pueblo, CO 45 35 7 3 — — 5
Detroit, MI 88 51 26 7 3 1 5 Salt Lake City, UT 127 84 25 12 2 2 8
Evansville, IN 50 40 9 — — 1 5 Tucson, AZ 183 132 37 7 1 3 11
Fort Wayne, IN 74 52 16 3 2 1 7 Pacific 1,709 1,215 341 83 42 28 163
Gary, IN 4 4 — — — — 1 Berkeley, CA 12 9 2 — — 1 2
Grand Rapids, MI 51 40 8 2 — 1 4 Fresno, CA 119 76 34 5 2 2 14
Indianapolis, IN 188 116 55 10 4 3 6 Glendale, CA 42 35 5 2 — — 6
Lansing, MI 48 37 8 2 1 — 2 Honolulu, HI 53 43 8 1 — 1 4
Milwaukee, WI 78 53 21 3 — 1 2 Long Beach, CA 64 49 10 2 3 — 5
Peoria, IL 42 32 7 — — 3 2 Los Angeles, CA 259 175 48 22 7 7 34
Rockford, IL 55 40 10 4 — 1 3 Pasadena, CA 21 19 1 — — 1 2
South Bend, IN 44 36 7 — — 1 2 Portland, OR 120 74 30 9 4 3 4
Toledo, OH 91 67 18 3 1 2 3 Sacramento, CA 236 175 44 12 3 2 29
Youngstown, OH 65 51 12 2 — — 7 San Diego, CA 147 100 28 7 7 5 10
W.N. Central 522 362 117 22 9 12 30 San Francisco, CA 109 73 30 5 — 1 8
Des Moines, IA 69 52 12 2 — 3 4 San Jose, CA 190 152 27 3 6 2 22
Duluth, MN 13 13 — — — — — Santa Cruz, CA 25 18 7 — — — 2
Kansas City, KS 33 22 7 2 2 — 4 Seattle, WA 88 57 23 6 — 2 9
Kansas City, MO 105 69 24 7 2 3 5 Spokane, WA 63 48 10 1 3 1 3
Lincoln, NE 49 43 4 1 1 — 1 Tacoma, WA 161 112 34 8 7 — 9
Minneapolis, MN 37 22 12 1 1 1 2 Total¶ 11,271 7,651 2,586 613 227 186 813
Omaha, NE 90 57 25 3 2 3 6
St. Louis, MO U U U U U U U
St. Paul, MN 32 22 9 1 — — 3
Wichita, KS 94 62 24 5 1 2 5
U: Unavailable.   —: No reported cases.   
* Mortality data in this table are voluntarily reported from 122 cities in the United States, most of which have populations of >100,000. A death is reported by the place of its occurrence and 
by the week that the death certificate was filed. Fetal deaths are not included.
† Pneumonia and influenza.
§ Because of changes in reporting methods in this Pennsylvania city, these numbers are partial counts for the current week. Complete counts will be available in 4 to 6 weeks.
¶ Total includes unknown ages.
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